WO2009038030A1 - Gel sheet and sheet-like cosmetic material using the same - Google Patents
Gel sheet and sheet-like cosmetic material using the same Download PDFInfo
- Publication number
- WO2009038030A1 WO2009038030A1 PCT/JP2008/066614 JP2008066614W WO2009038030A1 WO 2009038030 A1 WO2009038030 A1 WO 2009038030A1 JP 2008066614 W JP2008066614 W JP 2008066614W WO 2009038030 A1 WO2009038030 A1 WO 2009038030A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gel sheet
- hydrogel
- gel
- sheet
- mass
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 35
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 239000000499 gel Substances 0.000 claims abstract description 306
- 239000000017 hydrogel Substances 0.000 claims abstract description 157
- 102000008186 Collagen Human genes 0.000 claims abstract description 51
- 108010035532 Collagen Proteins 0.000 claims abstract description 51
- 229920001436 collagen Polymers 0.000 claims abstract description 51
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 49
- 229920000642 polymer Polymers 0.000 claims abstract description 47
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 75
- 239000000839 emulsion Substances 0.000 claims description 57
- -1 oxypropylene group Chemical group 0.000 claims description 54
- 150000001875 compounds Chemical class 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 37
- 239000002245 particle Substances 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 35
- 229920001282 polysaccharide Polymers 0.000 claims description 32
- 239000005017 polysaccharide Substances 0.000 claims description 32
- 239000000758 substrate Substances 0.000 claims description 30
- 229910052751 metal Inorganic materials 0.000 claims description 28
- 239000002184 metal Substances 0.000 claims description 28
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 21
- 229920006318 anionic polymer Polymers 0.000 claims description 17
- 229920000570 polyether Polymers 0.000 claims description 16
- 229920001451 polypropylene glycol Polymers 0.000 claims description 16
- 235000021466 carotenoid Nutrition 0.000 claims description 14
- 150000001747 carotenoids Chemical class 0.000 claims description 14
- 150000005846 sugar alcohols Polymers 0.000 claims description 11
- 229920001289 polyvinyl ether Polymers 0.000 claims description 6
- 125000000524 functional group Chemical group 0.000 claims description 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000006353 oxyethylene group Chemical group 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims 3
- 239000000284 extract Substances 0.000 description 111
- 239000004480 active ingredient Substances 0.000 description 61
- 239000010410 layer Substances 0.000 description 61
- 210000003491 skin Anatomy 0.000 description 57
- 108010010803 Gelatin Proteins 0.000 description 46
- 229920000159 gelatin Polymers 0.000 description 46
- 235000019322 gelatine Nutrition 0.000 description 46
- 235000011852 gelatine desserts Nutrition 0.000 description 46
- 239000008273 gelatin Substances 0.000 description 45
- 238000000034 method Methods 0.000 description 37
- 239000000047 product Substances 0.000 description 29
- 150000004804 polysaccharides Chemical class 0.000 description 27
- 229920001577 copolymer Polymers 0.000 description 26
- 239000000203 mixture Substances 0.000 description 20
- 230000036572 transepidermal water loss Effects 0.000 description 20
- 239000000853 adhesive Substances 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 17
- 229920001477 hydrophilic polymer Polymers 0.000 description 17
- 229920002148 Gellan gum Polymers 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 16
- 235000010492 gellan gum Nutrition 0.000 description 16
- 239000000216 gellan gum Substances 0.000 description 16
- 230000001070 adhesive effect Effects 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 239000003205 fragrance Substances 0.000 description 13
- 230000006872 improvement Effects 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- 229920001400 block copolymer Polymers 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000004744 fabric Substances 0.000 description 9
- 230000035699 permeability Effects 0.000 description 9
- 230000001681 protective effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 108010076876 Keratins Proteins 0.000 description 8
- 102000011782 Keratins Human genes 0.000 description 8
- 239000004721 Polyphenylene oxide Substances 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 8
- 239000001913 cellulose Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 8
- 239000004745 nonwoven fabric Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 230000008591 skin barrier function Effects 0.000 description 8
- 238000005063 solubilization Methods 0.000 description 8
- 230000007928 solubilization Effects 0.000 description 8
- 239000004753 textile Substances 0.000 description 8
- 238000002834 transmittance Methods 0.000 description 8
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000007721 medicinal effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 7
- 235000010493 xanthan gum Nutrition 0.000 description 7
- 229940082509 xanthan gum Drugs 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229920001661 Chitosan Polymers 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 6
- 239000004677 Nylon Substances 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 235000013793 astaxanthin Nutrition 0.000 description 6
- 229920001778 nylon Polymers 0.000 description 6
- 229920001983 poloxamer Polymers 0.000 description 6
- 229920001992 poloxamer 407 Polymers 0.000 description 6
- 229920001059 synthetic polymer Polymers 0.000 description 6
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 5
- 238000005266 casting Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 229960002337 magnesium chloride Drugs 0.000 description 5
- 229920000609 methyl cellulose Polymers 0.000 description 5
- 235000010981 methylcellulose Nutrition 0.000 description 5
- 239000001923 methylcellulose Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002985 plastic film Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 229960000834 vinyl ether Drugs 0.000 description 5
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 229920000926 Galactomannan Polymers 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 229920002581 Glucomannan Polymers 0.000 description 4
- 235000009827 Prunus armeniaca Nutrition 0.000 description 4
- 244000018633 Prunus armeniaca Species 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 240000006365 Vitis vinifera Species 0.000 description 4
- 235000014787 Vitis vinifera Nutrition 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- 230000001741 anti-phlogistic effect Effects 0.000 description 4
- 229940064004 antiseptic throat preparations Drugs 0.000 description 4
- 239000001168 astaxanthin Substances 0.000 description 4
- 229940022405 astaxanthin Drugs 0.000 description 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 238000002296 dynamic light scattering Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 229940046240 glucomannan Drugs 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 229920005615 natural polymer Polymers 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 229920006255 plastic film Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000003578 releasing effect Effects 0.000 description 4
- 230000036548 skin texture Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- 229940015975 1,2-hexanediol Drugs 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 229920000298 Cellophane Polymers 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000002390 adhesive tape Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 3
- 239000000626 magnesium lactate Substances 0.000 description 3
- 235000015229 magnesium lactate Nutrition 0.000 description 3
- 229960004658 magnesium lactate Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000004043 responsiveness Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 231100000245 skin permeability Toxicity 0.000 description 3
- 239000008279 sol Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BAPRUDZDYCKSOQ-RITPCOANSA-N (2s,4r)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound CC(=O)N1C[C@H](O)C[C@H]1C(O)=O BAPRUDZDYCKSOQ-RITPCOANSA-N 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- LUYISICIYVKBTA-UHFFFAOYSA-N 6-methylquinoline Chemical compound N1=CC=CC2=CC(C)=CC=C21 LUYISICIYVKBTA-UHFFFAOYSA-N 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000131283 Cantharis Species 0.000 description 2
- 241000251730 Chondrichthyes Species 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 244000301850 Cupressus sempervirens Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 229920000855 Fucoidan Polymers 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 241000168517 Haematococcus lacustris Species 0.000 description 2
- 240000008669 Hedera helix Species 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 235000008694 Humulus lupulus Nutrition 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- FPCCDPXRNNVUOM-UHFFFAOYSA-N Hydroxycitronellol Chemical compound OCCC(C)CCCC(C)(C)O FPCCDPXRNNVUOM-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 241000406668 Loxodonta cyclotis Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 244000025272 Persea americana Species 0.000 description 2
- 240000009164 Petroselinum crispum Species 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 241001125048 Sardina Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 2
- 229920006322 acrylamide copolymer Polymers 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229920001586 anionic polysaccharide Polymers 0.000 description 2
- 150000004836 anionic polysaccharides Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 150000001514 astaxanthins Chemical class 0.000 description 2
- 125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 2
- 239000011774 beta-cryptoxanthin Substances 0.000 description 2
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000010376 calcium ascorbate Nutrition 0.000 description 2
- 229940047036 calcium ascorbate Drugs 0.000 description 2
- 239000011692 calcium ascorbate Substances 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229960002376 chymotrypsin Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002734 clay mineral Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 235000002532 grape seed extract Nutrition 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 235000010181 horse chestnut Nutrition 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- CZVXBFUKBZRMKR-UHFFFAOYSA-N lavandulol Chemical compound CC(C)=CCC(CO)C(C)=C CZVXBFUKBZRMKR-UHFFFAOYSA-N 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- GGHMUJBZYLPWFD-UHFFFAOYSA-N patchoulialcohol Chemical compound C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- XWIHRGFIPXWGEF-UHFFFAOYSA-N propafenone hydrochloride Chemical compound Cl.CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 XWIHRGFIPXWGEF-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 229920001221 xylan Polymers 0.000 description 2
- 150000004823 xylans Chemical class 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical class OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 1
- QLRNLHNEZFMRSR-SOFGYWHQSA-N (4e)-3,7-dimethylocta-4,6-dien-3-ol Chemical compound CCC(C)(O)\C=C\C=C(C)C QLRNLHNEZFMRSR-SOFGYWHQSA-N 0.000 description 1
- JYCZANGPRHNMQU-UHFFFAOYSA-N (6-hydroxy-6-methoxycyclohexa-2,4-dien-1-yl)-phenylmethanone Chemical compound COC1(O)C=CC=CC1C(=O)C1=CC=CC=C1 JYCZANGPRHNMQU-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 239000001306 (7E,9E,11E,13E)-pentadeca-7,9,11,13-tetraen-1-ol Substances 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- YDXQPTHHAPCTPP-AATRIKPKSA-N (E)-3-Octen-1-ol Chemical compound CCCC\C=C\CCO YDXQPTHHAPCTPP-AATRIKPKSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- CZVXBFUKBZRMKR-JTQLQIEISA-N (R)-lavandulol Natural products CC(C)=CC[C@@H](CO)C(C)=C CZVXBFUKBZRMKR-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- WAPNOHKVXSQRPX-UHFFFAOYSA-N 1-phenylethanol Chemical compound CC(O)C1=CC=CC=C1 WAPNOHKVXSQRPX-UHFFFAOYSA-N 0.000 description 1
- FDZSOJOJVCBNNI-UHFFFAOYSA-N 1-tert-butylcyclohexan-1-ol Chemical compound CC(C)(C)C1(O)CCCCC1 FDZSOJOJVCBNNI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QSKPZDMBULYMDQ-UHFFFAOYSA-N 2,3-dihydroxypropyl pentadecanoate Chemical compound CCCCCCCCCCCCCCC(=O)OCC(O)CO QSKPZDMBULYMDQ-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- LIPHCKNQPJXUQF-SDNWHVSQSA-N 2-Benzylidene-1-heptanol Chemical compound CCCCC\C(CO)=C/C1=CC=CC=C1 LIPHCKNQPJXUQF-SDNWHVSQSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- QLIBJPGWWSHWBF-UHFFFAOYSA-N 2-aminoethyl methacrylate Chemical compound CC(=C)C(=O)OCCN QLIBJPGWWSHWBF-UHFFFAOYSA-N 0.000 description 1
- AIFLGMNWQFPTAJ-UHFFFAOYSA-J 2-hydroxypropanoate;titanium(4+) Chemical compound [Ti+4].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O AIFLGMNWQFPTAJ-UHFFFAOYSA-J 0.000 description 1
- JZICUKPOZUKZLL-UHFFFAOYSA-N 2-methyl-1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2NC(C)CCC2=C1 JZICUKPOZUKZLL-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- BDCFWIDZNLCTMF-UHFFFAOYSA-N 2-phenylpropan-2-ol Chemical compound CC(C)(O)C1=CC=CC=C1 BDCFWIDZNLCTMF-UHFFFAOYSA-N 0.000 description 1
- DLHQZZUEERVIGQ-UHFFFAOYSA-N 3,7-dimethyl-3-octanol Chemical compound CCC(C)(O)CCCC(C)C DLHQZZUEERVIGQ-UHFFFAOYSA-N 0.000 description 1
- PRNCMAKCNVRZFX-UHFFFAOYSA-N 3,7-dimethyloctan-1-ol Chemical compound CC(C)CCCC(C)CCO PRNCMAKCNVRZFX-UHFFFAOYSA-N 0.000 description 1
- AEJRTNBCFUOSEM-UHFFFAOYSA-N 3-Methyl-1-phenyl-3-pentanol Chemical compound CCC(C)(O)CCC1=CC=CC=C1 AEJRTNBCFUOSEM-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 1
- LHJCLTLPXXKFTJ-UHFFFAOYSA-N 3-[4-hydroxy-3-(4-hydroxy-3-prop-2-enylphenyl)phenyl]propane-1,2-diol Chemical compound OCC(O)CC1=CC=C(O)C(C=2C=C(CC=C)C(O)=CC=2)=C1 LHJCLTLPXXKFTJ-UHFFFAOYSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- INIOTLARNNSXAE-UHFFFAOYSA-N 4,8-dimethyl-2-propan-2-ylidene-3,3a,4,5,6,8a-hexahydro-1h-azulen-6-ol Chemical compound CC1CC(O)C=C(C)C2CC(=C(C)C)CC12 INIOTLARNNSXAE-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- YXVSKJDFNJFXAJ-UHFFFAOYSA-N 4-cyclohexyl-2-methylbutan-2-ol Chemical compound CC(C)(O)CCC1=CC=CC=C1 YXVSKJDFNJFXAJ-UHFFFAOYSA-N 0.000 description 1
- DUFCMRCMPHIFTR-UHFFFAOYSA-N 5-(dimethylsulfamoyl)-2-methylfuran-3-carboxylic acid Chemical compound CN(C)S(=O)(=O)C1=CC(C(O)=O)=C(C)O1 DUFCMRCMPHIFTR-UHFFFAOYSA-N 0.000 description 1
- QGFSQVPRCWJZQK-UHFFFAOYSA-N 9-Decen-1-ol Chemical compound OCCCCCCCCC=C QGFSQVPRCWJZQK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- MKGRMAIAGDEUTL-XYCHTSNDSA-N Actinioerythrol Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)C2(C)C MKGRMAIAGDEUTL-XYCHTSNDSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 241000157280 Aesculus hippocastanum Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- WZUKKIPWIPZMAS-UHFFFAOYSA-K Ammonium alum Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O WZUKKIPWIPZMAS-UHFFFAOYSA-K 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 241001105098 Angelica keiskei Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000213948 Astragalus sinicus Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000007089 Chlorella vulgaris Nutrition 0.000 description 1
- 240000009108 Chlorella vulgaris Species 0.000 description 1
- 235000021513 Cinchona Nutrition 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001938 Citrus medica Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 244000265913 Crataegus laevigata Species 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- 235000017156 Crataegus rhipidophylla Nutrition 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000445924 Epiphyllum <angiosperm> Species 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000308505 Filipendula ulmaria Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 235000002873 Gentiana lutea Nutrition 0.000 description 1
- 240000003409 Gentiana lutea Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 241000208681 Hamamelis virginiana Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 1
- 244000130592 Hibiscus syriacus Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 1
- 241001357959 Hydrangea serrata Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 240000007171 Imperata cylindrica Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- OKPQBUWBBBNTOV-UHFFFAOYSA-N Kojibiose Natural products COC1OC(O)C(OC2OC(OC)C(O)C(O)C2O)C(O)C1O OKPQBUWBBBNTOV-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 150000000994 L-ascorbates Chemical class 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 235000003127 Lactuca serriola Nutrition 0.000 description 1
- 240000006137 Lactuca serriola Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 244000045575 Luffa cylindrica Species 0.000 description 1
- 235000010649 Lupinus albus Nutrition 0.000 description 1
- 240000000894 Lupinus albus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000733295 Lysichiton camtschatcensis Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- GGHMUJBZYLPWFD-MYYUVRNCSA-N Patchouli alcohol Natural products O[C@@]12C(C)(C)[C@H]3C[C@H]([C@H](C)CC1)[C@]2(C)CC3 GGHMUJBZYLPWFD-MYYUVRNCSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 235000011236 Persea americana var americana Nutrition 0.000 description 1
- 235000003823 Petasites japonicus Nutrition 0.000 description 1
- 240000003296 Petasites japonicus Species 0.000 description 1
- 235000002770 Petroselinum crispum Nutrition 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000003500 Ruscus aculeatus Nutrition 0.000 description 1
- 240000000353 Ruscus aculeatus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- 241000580938 Sapindus Species 0.000 description 1
- 240000003946 Saponaria officinalis Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 244000078879 Saxifraga sarmentosa Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 235000021525 Tilia platyphyllos Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 241000949456 Zanthoxylum Species 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 229940105017 achillea millefolium extract Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 229940119459 acorus calamus root extract Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XPNGNIFUDRPBFJ-UHFFFAOYSA-N alpha-methylbenzylalcohol Natural products CC1=CC=CC=C1CO XPNGNIFUDRPBFJ-UHFFFAOYSA-N 0.000 description 1
- 235000011124 aluminium ammonium sulphate Nutrition 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940024545 aluminum hydroxide Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 239000001180 angelica archangelica l. root extract Substances 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229940019834 apocarotenal Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 229940084830 artemisia capillaris flower extract Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- LCPUDZUWZDSKMX-UHFFFAOYSA-K azane;hydrogen sulfate;iron(3+);sulfate;dodecahydrate Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCPUDZUWZDSKMX-UHFFFAOYSA-K 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000001436 butterbur Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940119162 calendula officinalis flower extract Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000018889 capsanthin Nutrition 0.000 description 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920006319 cationized starch Polymers 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 229940059458 citrus junos seed extract Drugs 0.000 description 1
- 229940082471 clematis vitalba leaf extract Drugs 0.000 description 1
- 229940082834 cnidium officinale root extract Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940084783 coptis japonica root extract Drugs 0.000 description 1
- 229940116815 crocus sativus flower extract Drugs 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 229960000729 cyclandelate Drugs 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- SILCDLWESNHZKB-UHFFFAOYSA-L disodium 4-hydroxy-4-oxobutanoate Chemical compound [Na+].[Na+].OC(=O)CCC([O-])=O.OC(=O)CCC([O-])=O SILCDLWESNHZKB-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229960004887 ferric hydroxide Drugs 0.000 description 1
- 229940032950 ferric sulfate Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 1
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 229940119204 hibiscus sabdariffa flower extract Drugs 0.000 description 1
- 235000020345 hibiscus tea Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- 229940027897 ichthammol Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 description 1
- YHGPYBQVSJBGHH-UHFFFAOYSA-H iron(3+);trisulfate;pentahydrate Chemical compound O.O.O.O.O.[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O YHGPYBQVSJBGHH-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 229940062851 jujube fruit extract Drugs 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- PZDOWFGHCNHPQD-OQPGPFOOSA-N kojibiose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-OQPGPFOOSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 229940099576 lamium album extract Drugs 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229940073548 lilium candidum bulb extract Drugs 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- JFQQIWNDAXACSR-UHFFFAOYSA-L magnesium malate Chemical compound [Mg+2].[O-]C(=O)C(O)CC([O-])=O JFQQIWNDAXACSR-UHFFFAOYSA-L 0.000 description 1
- 229940096424 magnesium malate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004701 malic acid derivatives Chemical class 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- VLPIATFUUWWMKC-UHFFFAOYSA-N mexiletine Chemical compound CC(N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-UHFFFAOYSA-N 0.000 description 1
- 229960001070 mexiletine hydrochloride Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229940116733 morus alba leaf extract Drugs 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 125000005487 naphthalate group Chemical group 0.000 description 1
- 229940079224 nasturtium officinale extract Drugs 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- 229940061591 parietaria officinalis extract Drugs 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940104701 pinus sylvestris cone extract Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GNHOJBNSNUXZQA-UHFFFAOYSA-J potassium aluminium sulfate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GNHOJBNSNUXZQA-UHFFFAOYSA-J 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 239000001521 potassium lactate Substances 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960005335 propanol Drugs 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940074112 pyracantha fortuneana fruit extract Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 229940073140 rosa canina fruit extract Drugs 0.000 description 1
- 239000001228 rosa centifolia flower Substances 0.000 description 1
- 229940046326 rosa centifolia flower extract Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 229940052850 sambucus nigra flower extract Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229940074386 skatole Drugs 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- KMPHTYSTEHXSTL-UHFFFAOYSA-M sodium;2-hydroxypropanoate;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O.CC(O)C([O-])=O KMPHTYSTEHXSTL-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 238000001370 static light scattering Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229940069762 swertia japonica extract Drugs 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229920000208 temperature-responsive polymer Polymers 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 229940095051 vaccinium vitis-idaea leaf extract Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/608—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Definitions
- the present invention relates to a gel sheet used in the fields such as pharmaceuticals, quasi-drugs, cosmetics, sanitary materials, and miscellaneous goods, and a sheet-like cosmetic material using the gel sheet.
- Gel sheets are used for a pack material and an adhesive agent used for the beauty and facial treatments and skin therapies; carriers for active ingredients such as a skin permeable component, and an antiphlogistic analgetic; an adhesive tape for living bodies aimed at the protection against wound or the fixation of drug; and an injury-covering agent.
- These gel sheets protect the surface of the skin by adhering on the surface of the skin, impart a water retentivity to the skin surface, and contain various ingredients in the gel sheet, thereby imparting a water content (water retentivity) and controlling the temperature of the skin, or exhibiting functions for supplying active ingredients in the gel sheet to living bodies.
- an increase in the temperature and water content of the skin can promote the migration of active ingredients due to permeation of the active ingredients in a sheet into the skin.
- a gel sheet having such a function contains collagen, and polysaccharides such as chitin, chitosan, alginic acicl and cellulose, as a constituent component (for example, see, Japanese patent Application Laid-Open (JP-A) No. 3-81213).
- JP-A Japanese patent Application Laid-Open
- a temperature-sensitive change-of-state hydrogel composition a technology, in which a drug in a hydrogel is medicated into the skin due to the change of the state from the gel to a flowable state by the body temperature when the hydrogel contacts the skin, has been known (for example, see, Published Japanese Translation of PCT International Publication for Patent Application (JP-T) No. 2007-502269).
- an adhesive sheet comprising a temperature-responsive polymer having a transition temperature of from 4 to 34 0 C and an adhesive polymer (for example, see, JP-ANo. 5-184657), and a temperature-responsive gel sheet recognized in a temperature-responsive hydrogel formed from a particular polyether ester, (for example, see, JP-ANo. 11-92554) have been known.
- an object of the present invention is to provide a gel sheet having improved permeability with respect to water or active ingredients upon contacting an adherend such as an epidermis and the like, and excellent handling characteristics, and a sheet-like cosmetic material using the gel sheet.
- a first aspect of the invention provides a gel sheet comprising a hydrogel which comprises an ether-based temperature-sensitive polymer, and at least one of collagen or decomposition products of collagen.
- a second aspect of the invention provides a sheet- like cosmetic material using any one of the gel sheets described above.
- the invention can provide a gel sheet and a sheet-like cosmetic material using the gel sheet with an improved permeability of water or active ingredients in the sheet by bringing the gel sheet into contact with an adherend such as the epidermis and the like, and excellent handling characteristics.
- the gel sheet of the present invention contains an ether-based temperature-sensitive polymer, and at least one of collagen and decomposition product thereof.
- the ether-based temperature-sensitive polymer of the above gel sheet is preferably at least one selected from the group consisting of polyethers, polyvinyl ethers, and alkylated polysaccharide derivatives, more preferably a block polymer containing polyethylene oxide and polypropylene oxide.
- the gel sheet may contain an O/W type emulsion, and the O/W type emulsion may contain a carotenoid.
- the gel sheet of the present invention is preferably those that a syneresis liquid of the gel sheet contains the emulsified particles of the O/W type emulsion.
- the gel sheet of the present invention preferably comprises a hydrogel layer containing the hydrogel and a sheet-like substrate provided in the hydrogel layer or adjacent to the hydrogel gel layer.
- the "gel sheet” includes gel sheets used for a pack material and an adhesive agent used for the beauty and facial treatments and skin therapies, carriers for active ingredients such as a skin permeable component, an antiphlogistic analgetic, an adhesive tape for living bodies aimed at the protection against wound or the fixation of drug, and an injury-covering agent, and refers to a sheet which retains active ingredients or water, and is used by directly adhering the sheet to an adherend for the purpose of permeating the retained components to the adherend.
- the gel sheet is useful as cosmetic materials such as a pack agent for being adhered onto the skin to provide the skin with water or active ingredients.
- the gel sheet of the invention contains a gel sheet containing an ether-based temperature-sensitive polymer, and at least one of collagen and decomposition product thereof.
- the ether-based temperature-sensitive polymer used in the invention causes the dehydration with an increase in temperature.
- the conformation of collagen or gelatin which is a decomposition product of collagen varies with an increase in temperature.
- the combined use of the ether-based temperature-sensitive polymer and collagen or its decomposition product having such properties enables the control of a releasing amount of active ingredients such as medical properties contained in the hydrogel, and the maintenance of an appropriate shape strength of the hydrogel.
- the gel sheet containing the hydrogel is useful for a sheet-like cosmetic material for providing moisture-retaining property and for permeating active ingredients into the skin. [0012] (Hydrogel) ⁇ Ether-based Temperature-Sensitive Polymer >
- the hydrogel used for the invention contains an ether-based temperature-sensitive polymer.
- the ether-based temperature-sensitive polymer of the invention refers to a polymer which hydrates at a certain temperature or less in the presence of water, and when this temperature is exceeded, dehydrates and thereby undergoes a conformation change.
- These microscopic changes induced by the temperature changes appear as macroscopic changes such as a change in volume, a hydrophilic-hydrophobic change, an optical change, a swelling-contraction change and the like.
- the "certain temperature” is referred to as the temperature of the lower critical consolute temperature, and from the viewpoint of an increase in the skin permeability of water or active ingredients when adhering the gel sheet to living bodies, the temperature is preferably from 20 to 40°C, and more preferably from 25 to 30°C.
- the ether-based temperature-sensitive polymer used in the invention has the above temperature-sensitive characteristic, and any polymer can be used without limitation as long as the polymer has an ether bond. From the viewpoint of the compatibility of the responsiveness to temperature and the stability during storage, the ether-based temperature-sensitive polymer has preferably a weight average molecular weight (Mw) of from 5,000 to 1,000,000, and more preferably from 10,000 to 500,000.
- ether-based temperature-sensitive polymers selected from the group consisting of polyethers, vinylethers and alkylated polysaccharide derivatives is preferable, and examples thereof include the following compounds:
- polyethers for example, polyethylene oxide, polypropylene oxide, polyethylene oxide/polypropylene oxide block copolymer, polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer, and the like can be preferably exemplified.
- polyvinyl ethers for example, polymethyl vinylether, polyethyl vinylether, polymethoxyethyl vinylether, polyethoxyethyl polyvinylether, and the like can be preferably exemplified.
- alkylated polysaccharide derivatives for example, methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropyl methylcellulose, ethyl cellulose, hydroxypropyl chitosan, and the like can be preferably exemplified.
- the polyethers, polyvinylethers and alkylated polysaccharide derivatives have preferably at least one or more functional groups selected from the group consisting of an oxyethylene group, an oxypropylene group, a methoxy group and an ethoxy group, and in the above examples, polyethylene oxide/polypropylene oxide block copolymer, polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer, polymethyl vinylether, methylcellulose, and the like are preferable.
- a block polymer containing polyethylene oxide and polypropylene oxide is particularly preferable, and more specifically, polyethylene oxide/polypropylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO block polymer”), or polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO-PEO block polymer”) is desirable.
- PEO-PPO block polymer polyethylene oxide/polypropylene oxide block copolymer
- PEO-PPO-PEO block polymer polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer
- polyethers are known as a poloxamer, and are easily available as commercial products, under the trade name of "PLURONIC” and “LUTROL (both are manufactured by BASF A.G.), NEWPOL (manufactured by Sanyo Chemical Industries, Ltd.), and EPAN (manufactured by Dai-Ichi Kogyo Seiyaku Co., Ltd.), PRONON (manufactured by Nippon Oil & Fats Co., Ltd.), and the like.
- the above ether-based temperature-sensitive polymer can be used singly, or a mixture of two or more can be used [0018]
- the content of the ether-based temperature-sensitive polymer in the hydrogel used in the invention is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferably from 0.2 to 5% by mass.
- the hydrogel used in the invention includes collagen and the decomposition product thereof.
- Collagen herein is not specifically limited, but includes various collagen extracts. Extraction can be performed using collagen-containing raw materials by known techniques such as acid solubilization, alkali solubilization, neutral salt solubilization and enzyme solubilization. As far as the materials contain collagen, any materials can be used, and the skin, scale, bone, gristle, tendon and vertebrata (for example, cattle, pig, sardine, shark and the like) can be exemplified, and in view of a high content of collagen, bones, gristles, skins or scale, tendons, placentae and the like can suitably be used. In particular, collagen used suitably in the invention is preferably water-soluble collagen.
- the decomposition products of collagen in the invention can be obtained by decomposing the collagen with a proteolytic enzyme such as collagenase, trypsin, and chymotrypsin, or by hydrolyzing with an acid or an alkali, or by denaturing with heat.
- a proteolytic enzyme such as collagenase, trypsin, and chymotrypsin
- collagen decomposition products for example, acid-processed gelatin, alkali-processed gelatin, enzyme decomposition gelatin, collagen tripeptide, collagen dipeptide, and amino acids (glycine, proline, hydroxyproline, acetylhydroxyproline and the like) are exemplified.
- At least one of gelatin or gelatin derivatives is preferable among the collagen and the decomposition products of collagen.
- the gelatin is a hydrolyzed protein of collagen.
- the production methods of the gelatin are not specifically limited, and the gelatin is commonly manufactured by a acid process or an alkali process from cattle bones, cattle skins, pig skins and fish scale, and the like as raw materials, but may be manufactured by an enzyme method.
- gelatin derivatives known derivatives can be used.
- acid anhydride adducts of gelatin for example, phthalated gelatin, succinated gelatin, trimellited gelatin and the like
- lactone adducts glucono- ⁇ -lactone adduct gelatin, and the like
- acylated gelatin acetylated gelatin, and the like
- esterified gelatin methylesterified gelatin, and the like
- organic acid salt of gelatin gelatin acetate, gelatin stearate, gelatin benzoate
- gelatin and the derivatives thereof used for the gel sheet of the invention gelatin derived from pig skin, gelatin derived from fish, succinated gelatin, phthalated gelatin, and trimellited gelatin are desirable from the viewpoint of the affinity with living bodes and the releasing property of active ingredients.
- a gelatin may be used singly, or a combination of two or more of gelatins may be used, a gelatin derivative may be used singly, or a combination of two or more of gelatin derivatives may be used, or a mixture of gelatin and gelatin derivatives may be used.
- the weight average molecular weight of the gelatin and gelatin derivative in the invention is preferably from 5,000 to 1,000,000, more preferably from 5,000 to 300,000, and particularly preferable from 10,000 to 300,000, as the weight average molecular weight measured by the gel permeation chromatography (GPC).
- the content of the collagen and the decomposition product of collagen contained in the hydrogel in the invention is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferable from 0.2 to 5% by mass.
- the content of the collagen and decomposition product of collagen of 0.05% by mass or more is effective to the permeability of active ingredients in the hydrogel into the skin, and when the content is 20% by mass or less, the handling characteristics become good.
- the mass ratio of the ether-based temperature-sensitive polymer to the collagen and decomposition product thereof is preferably from 1:50 to 50:1, more preferably from 1 : 10 to 10: 1 , and particularly preferably from 1 :5 to 5:1 in view of the permeability of active ingredients into the skin.
- the gel sheet of the invention further contains preferably other components such as polyhydric alcohol compounds, an O/W type emulsion, and polysaccharides, in the hydrogel. Furthermore, a hydrophilic polymer and the like may also be contained, if needed. [0031 ] ⁇ Polyhydric Alcohol Compound >
- the gel sheet of the invention preferably further contains polyhydric alcohol compounds.
- the polyhydric alcohol compounds include, specifically, glycerins (glycerin, diglycerin and the like); glycols (for example, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol, 1,2-propanediol, 1,3 -propanediol, dipropylene glycol, 1,2-butanediol, 1,3-butanediol, 1 ,2-pentanediol, 1,2-hexanediol, 1 ,2-octanediol, and the like), saccharides (glucose, fructose, mannose, galactose, xylose, arabinose, glucosamine, N-acetylglucosamine, sucrose, lactose, maltose, isomaltose, trehalose, cellobiose, kojibiose, sophorose, maltotriose, r
- the above polyhydric alcohol compound may be used singly, or a mixture of two or more may be used.
- glycerins or glycols are preferably used in the gel sheet of the invention, in particular, glycerin, 1,2-propanediol, 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, and 1,3-butanediol are more desirable.
- glycerin, 1,2-propanediol, 1,3-butanediol, and 1,2-hexanediol are particularly preferably used.
- the ratio of the polyhydric alcohol compounds contained in the hydrogel in the invention is preferably 50% by mass or less, and particularly preferably from 1 to 20 % by mass.
- the ratio of the polyhydric alcohol compounds contained in the hydrogel in the invention is preferably 50% by mass or less, thereby preventing reduction in the gel strength, and improving handling characteristics. [0035] ⁇ O/W Type Emulsion >
- the gel sheet of the invention contains preferably an O/W type emulsion.
- an O/W type emulsion containing oil-soluble active ingredients and medicinal properties is preferable.
- the components in the O/W type emulsion can be supplied to an adherend, so that the function of each component, for example, making the skin beautiful, can be enhanced by the skin permeation.
- oil-soluble active ingredients for example, lipid soluble vitamins and their related substances (tocopherol, tocotrienol, retinol, retinal, calciferol, and the like), sterols (cholesterol, phytosterol, and the like), ubiquinones (CoQlO and the like), and a sphingolipid, a ceramide, a oryzanol, a squalene, a squalane, a carotenoid, and the like, and derivatives thereof are still desirable, and in the invention, the carotenoid is especially preferable.
- lipid soluble vitamins and their related substances tocopherol, tocotrienol, retinol, retinal, calciferol, and the like
- sterols cholesterol, phytosterol, and the like
- ubiquinones CoQlO and the like
- astaxanthin, lutein, zeaxanthin and ⁇ -cryptoxanthin are especially desirable, and astaxanthin, for which an antioxidant effect, an anti-inflammatory effect, an antiaging skin-care effect and a whitening effect are recognized, is particularly desirable.
- other components such as an emulsifier, which can generally be contained in each phase of an emulsion, may be contained in the O/W type emulsion composition in an amount of being generally used.
- other components such as polyhydric alcohols described in the present specification are included.
- the volume average particle diameter of the emulsified particles of the O/W type emulsion is preferably from lnm to 200nm, more preferably from lnm to 150nm, and particularly preferably from lnm to lOOnm.
- the volume average particle diameter can be measured with a commercial particle size distribution analyzer or the like.
- an optical microscopic method As the particle size measuring method of an emulsion, an optical microscopic method, a confocal laser scanning microscopic method, an electron microscopic method, an atomic force microscopic method, a static light scattering method, and a laser diffraction method, a dynamic light scattering method, a centrifugal sedimentation method, an electric pulse measuring method, a chromatographic method, an ultrasonic attenuation method, and the like are known, and apparatuses according to each measuring principle are on the market.
- the dynamic light scattering method is desirable for the measurement of the volume average particle diameter of the emulsion in the invention.
- NANOTRAC UPA Nikkiso Co., Ltd.
- LB-550 Horiba, Ltd.
- FPAR-1000 Oletsuka Electronics Co., Ltd.
- the values of the volume average particle diameter of the O/W type emulsion measured at 25°C by the thickened system particle size analyzer FPAR-1000 (manufacture by Otsuka Electronics Co., Ltd.), are adopted.
- the volume average particle diameter is measured with a measurement glass tube in such a manner that the emulsion is diluted with pure water so that the concentration of the oil phase becomes from 0.1 to 1% by mass.
- the volume average particle diameter can be obtained as an accumulative value (50%) when the refractive index of the dispersion medium is set to 1.3313 (pure water), and the viscosity of the dispersion medium is set to 0.8846mPa s (pure water).
- the method of producing the O/W type emulsion is not specifically limited, but, for example, the methods described in JP-A No. 2005-75817 can be used.
- the OAV type emulsion is preferably produced by a method comprising the steps of (a) forming a water phase prepared by dissolving a water-soluble emulsifier in an aqueous medium, (b) forming an oil phase by mixing and dissolving a carotenoid, a tocopherol, a lecithin, and optionally other oils and fats, and (c) mixing and emulsifying the water phase and the oil phase with stirring.
- the emulsion is further emulsified by being passed through a high pressure homogenizer or the like, so that two or more of emulsifying machines are used in combination.
- a high pressure homogenizer By the use of the high pressure homogenizer, an emulsion containing liquid droplets with a more uniform fine particle size can be obtained.
- the content of the O/W type emulsion in the hydrogel of the invention is preferably from 0.001 to 10% by mass, and more preferably from 0.05 to 1% by mass, from the viewpoint of the effects and permeation of active ingredients into the skin. Further, the content of oil soluble active ingredients in the hydrogel of the invention is preferably from 0.0001 to 10% by mass, and more preferably from 0.05 to 5% by mass, although the content of the oil-soluble active ingredients varies with the kind of the active ingredient.
- the content of the carotenoid in the hydrogel of the invention is preferably from 0.0001 to 0.5% by mass, more preferably from 0.0005 to 0.1% by mass, and particularly preferably from 0.001 to 0.05% by mass.
- the content of the carotenoid is 0.0001% by mass or more, the effects (making the skin beautiful or the like) after adhering the gel sheet of the invention onto the skin are felt, and when the content of the carotenoid is 0.5% by mass or less, unpleasant feelings are not apt to arise due to suppression of coloration of the skin.
- the polysaccharides which can be used for the invention include polysaccharides other than the above ether-based temperature-sensitive polymer, for example, neutral polysaccharides (for example, cellulose, amylose, amylopectin, agarose, dextran, pullulan, inulin, galactan, mannan, xylan, arabinan, glucomannan, galactomannan, and the like), and anionic polysaccharides (pectic acid, alginic acid, agar, carragheenan, fucoidan, hyaluronic acid, a chondroitin sulfate, heparin, gellan gum, native gellan gum, xanthan gum, carboxymethylcellulose, and the like), and cationic polysaccharides (chitin, chitosan, cationic cellulose, and the like).
- neutral polysaccharides for example, cellulose, amylose, amylopectin, agarose, dex
- polysaccharides with a high thickening gelling action is more preferable, and glucomannan, galactomannan, agar, carragheenan, gellan gum, native gellan gum, and xanthan gum are particularly preferable. In order to increasing the gelling action, two or more of these polysaccharides are used in combination.
- the content of the polysaccharide in the hydrogel of the invention is preferably from 0.01 to 5% by mass, more preferably from 0.1 to 4% by mass, and particularly preferably from 0.2 to 2% by mass.
- hydrophilic polymer can be added to the hydrogel of the gel sheet used for the invention for the purpose of improving a moisture-retaining property or the like, unless the solubility of the gel at the time of adhering the gel sheet to the skin is impaired. Further, the hydrophilic polymers can also be used for improving the shape stability of the gel sheet.
- the hydrophilic polymers which can be used in the invention may be polymer compounds other than the above ether-base temperature-sensitive polymers and the polysaccharides, and may be either synthetic or natural polymer compounds, as long as the polymer compounds have a hydrophilic functional group (for example, a hydroxyl group, a carboxyl group, a sulfo group, a phospho group, a carbamoyl group, an amino group, an ammonio group, an ethyleneoxy group, and the like). These polymer compounds may be used singly, or a mixture of two or more may be used.
- anionic polymer compounds such as a vinyl alcohol(co)polymer, a 2-hydroxyethyl acrylate(co)polymer, an acrylic acid(co)polymer, a methacrylic acid(co)polymer, a maleic acid(co)polymer, an itaconic acid(co)polymer, p-vinyl benzoic acid(co)polymer, 2-acrylamide-2-methyl-l-propanesulfonic acid(co)polymer and a styrene sulfonic acid(co)polymer, as well as an acrylamide(co)polymer, an acryloylmorpholine(co)polymer, an N-vinyl pyrrolidone(co)polymer, a vinyl amine(co)polymer, an N,N-dimethyldiallyl ammonium chloride(co)polymer,
- anionic polymer compounds such as a vinyl alcohol(co)polymer, a 2-hydroxy
- the content of the hydrophilic polymers is preferably from 0.05 to 5% by mass and more preferably from 0.1 to 3% by mass in the hydrogel, from the viewpoint of the moisture-retaining property and handling characteristics.
- An excipient may be preferably added to the hydrogel in the invention, for the purpose of further improvement of the shape stability of the gel sheet.
- organic or inorganic fine particles can suitably be used.
- organic fine particles known polystyrene particles, polymethacrylate particles, and crystallite cellulose are preferable.
- inorganic fine particles silica, alumina, calcium carbonate, kaolin, clay minerals, titanium oxide and the like are desirable. Among them, silica or clay minerals are preferable, and in particular, vapor phase silica and synthetic smectite having an average particle diameter of 200nm or less are particularly preferable.
- the ratio of the excipient contained in the hydrogel in the invention is preferably 10% by mass or less, and particularly preferably from 1 to 5% by mass. [0057] ⁇ Fragrance >
- a fragrance may be added to the hydrogel of the invention.
- the fragrance an alcohol-based fragrance, a phenol-based fragrance, a carboxylic acid-based fragrance, an amine-based fragrance and the like are exemplified.
- the gel sheet of the invention preferably further contains antiseptics for the purpose of the measure to deterioration by microbes.
- Antiseptics include, for example, phenol, benzoic acid and the salts thereof, salicylic acid and the salts thereof, p-hydroxybenzoates (methyl paraben, ethyl paraben, propyl paraben, butyl paraben), 2-phenoxyethanol, dehydroacetic acid and the salts thereof, sorbic acid and the salts thereof, alkylamino ethylglycine chloride, triclosan, benzalkonium chloride, ethanol, propanol, butanol, and the like. These compounds may be used singly, but are preferably used in combination. Among them, p-hydroxybenzoates and phenoxy ethanol are particularly preferable.
- the content of the antiseptics in the invention is preferably from 0.01 to 0.5% by mass, more preferably from 0.02 to 0.3% by mass, and particularly preferably from 0.03 to 0.2% by mass.
- the hydrogel of the invention may also further contain an organic acid from the viewpoint of controlling the pH value thereof.
- the organic acid includes acetic acid, ⁇ -hydroxy acid (for example, citric acid, lactic acid, gluconic acid, malic acid, succinic acid and the like), ascorbic acid, pyrrolidone carboxylic acid and the like. These compounds may be used singly, or a mixture of two or more may be used. The content of these compounds is preferably from 0.01 to 5% by mass, and more preferably from 0.05 to 2% by mass in the hydrogel. [0062] ⁇ Other Active Ingredients >
- the gel sheet of the invention may further contain various kinds of active ingredients or additives in accordance with the intended use of the sheet.
- active ingredients or additives the following compounds are exemplified: antioxidants (tocopherols, dibutyl hydroxytoluene, butyl hydroxyanisol, gallates, flavonoid, tannin, lignan, saponin and the like);
- ultraviolet absorbers p-methoxy cinnamic acid, octyl p-methoxycinnamate, 2-methoxy-2-hydroxybenzophenone, 2-ethylhexyl-p-dimethylaminobenzoate, and the like
- pH adjusters buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, succinic acid-sodium succinate, and the like
- chelating agents phytic acid, ethylenediamine tetraacetic acid, and the like
- surfactants polyglycerin fatty acid esters, sucrose fatty acid esters, lecithin, and the like
- vitamins vitamin A, B 1 , B 2 , B 6 , C, D, E, and derivatives thereof, pantothenic acid, biotin, nicotinic acid amide, vitamin-C ester, and the like
- vitamins vitamin A, B 1 , B 2 , B 6 , C, D, E
- amino acids glycine, trimethyl glycine, pyrrolidone carboxylic acid, serine, carnitine, ⁇ -amino butyric acid, taurine, threonine, asparagine, glutamine, thyrosin, lysine, histidine, arginine, aspartic acid, glutamic acid, ornithine, valine, leucine, and the like
- antiphlogistics glycyrrhitic acid derivatives, glycyrrhetic acid derivatives, salicylic acid derivatives, cypress thiol, zinc oxide, allantoin, and the like
- antiphlogistics glycyrrhitic acid derivatives, glycyrrhetic acid derivatives, salicylic acid derivatives, cypress thiol, zinc oxide, allantoin, and the like
- moisturizers urea, casein, soybean peptide, lactobacllus fermentation metabolism products, yeast fermentation metabolism products, honey, lactoferrin, albumin, hydrolyzed elastin, hydrolyzed keratin, hydrolyzed silk, ⁇ -hydroxy acid salt (for example, sodium lactate, potassium lactate, potassium gluconate, and the like), sodium pyrrolidone carboxylate, betaine and whey, and the like);
- whitening agents ascorbic acid glucoside, 3-O-ethyl ascorbic acid, arbutin, hydroquinone, kojic acid, lucinol, tranexamic acid, adenosine- 1 -sodium phosphate, magnolignan, ellagic acid, retinoid, rutin, resolcinol, cysteine, glutathione, linolic acid, and the like);
- various extracts for example, angelica keiskei extract, persea gratissima (avocado) fruit extract, hydrangea serrata leaf extract, althea extract, arnica extract, aloe extract, prunus armeniaca (apricot) kernel extract, prunus armeniaca (apricot) kernel extract, ginkgo biloba extract, foeniculum vulgare (fennel) extract, turmeric extract, oolong tea extract, rose fruit extract, echinacea angustifolia leaf exract, Scutellaria baicalensis root extract, phellodendron bark extract, coptis japonica root extract, hordeum vulgare seed extract, hypericum perforatum extract, lamium album extract, nasturtium officinale extract, citrus aurantium dulcis (orange) fruit extract, dehydrated seawater, seaweed extract, hydrolyzed elastin, hydrolyzed wheat powder, hydrolyzed silk, cham
- activation agents for example, royal jelly, sensitizer, cholesterol derivatives, and the like
- blood circulation accelerators for example, nonylic acid valenylamide, nicotinic acid benzylester, nicotinic acid ⁇ -buthoxy ethyl ester, capsaicin, zingerone, cantharis tincture, ichthammol, tannic acid, ⁇ -borneol, tocopherol nicotinate, inositol hexanicotinate, cyclandelate, cinnarizine, trazoline, acetylcholine, verapamil, cepharanthine, ⁇ -orizanol, and the like; antiseborrheic agents (for example, sulfur, thianthol, and the like), antiinflammatory agents (for example, tranexamic acid, thiotaurine, hypotaurine, ⁇ raminocaproic acid, glycyrr
- pyridoxine hydrochloride nicotinic acid, nicotinic acid derivatives, calcium pantothenate, D-pantothenyl alcohol, acetyl pantothenyl ethylether, isopropyl methylphenol, estradiol, ethynylestradiol, capronium chloride, diphenhydramine hydrochloride,Takanal, camphor, nonylic acid vanillylamide, nonanoic acid vanillylamide, Pirocton-Olamin, glyceryl pentadecanate, 1 -menthol, mononitro guaiacol, resorcin, benzethonium chloride, mexiletine hydrochloride, auxin, female hormone, cantharis tincture, cyclosporin, hydrocortisone, monostearic acid polyoxyethylene sorbitan, peppermint oil, and the like.
- the gel sheet if administration of medicines to living bodes by the skin permeation is possible, it is also possible to add medicinal properties such as painkillers, tranquilizers, antihypertensives, antibiotics, antihistamines, antimicrobials and the like, to the gel sheet.
- medicinal properties such as painkillers, tranquilizers, antihypertensives, antibiotics, antihistamines, antimicrobials and the like.
- One of these active ingredients can be used singly, or a combination of two or more can be used in accordance with the intended use of the gel sheet.
- the active ingredients contained in the hydrogel according to the invention may further contain the following components.
- the content of the ingredients and medicinal properties cannot generally be specified, but is generally preferably from 0.001 to 10% by mass, and more preferably from 0.05 to 5% by mass with respect to the total amount of the hydrogel. Further, similarly, in the case of moisturizers, the content thereof is generally preferably from 0.1 to 10% by mass, and more preferably from 0.5 to 5% by mass with respect to the total amount of the hydrogel. [0072] [Structure of Gel Sheet]
- the hydrogel may be formed in a single layer structure, or may also be formed in a multilayered structure with other layers. Further, a plurality of the hydrogel layers may be provided. Each ingredient as described in the above may be contained in the hydrogel layer, or may be contained in other layers, if possible. Furthermore, when the hydrogel layer is formed of plural layers, each of the ingredients may be contained in the same hydrogel layer, or may be contained in the plural layers, separately. Thus, when the gel sheet of the invention is formed of a plurality of hydrogel layers, the content of the above-described ingredients is the quantity contained in all the layers of the hydrogel layer constituting the gel sheet. [0073] ⁇ Sheet-like Substrate >
- a sheet-like substrate may be provided in the hydrogel layer or adjacent to the hydrogel gel layer.
- the sheet-like substrate is preferably provided from the viewpoint of the shape stability and handling characteristics of the gel sheet of the invention.
- a support layer or a protective sheet can be exemplified.
- the support layer is preferably provided, from the viewpoint of the shape stability and handling characteristics of the gel sheet of the invention, and the protective sheet is preferably provided, from the viewpoint of protecting the surface of the hydrogel layer surface until the use of the gel sheet.
- the support layer it is preferable to use known sheet-like substrates such as a nonwoven fabrics, textile fabrics or plastic films, crosslinked gels (gelatin/glutaraldehyde crosslinked gel, polyacrylic acid/polyvalent metal ion crosslinked gel, and the like), and physical gels (agarose gel, ⁇ -carrageenan gel, and the like), and as well as water-insoluble films formed from hydrophilic polymers (chitosan film, cellophane, ⁇ -carragheenan cast film, and the like) and the like.
- crosslinked gels gelatin/glutaraldehyde crosslinked gel, polyacrylic acid/polyvalent metal ion crosslinked gel, and the like
- physical gels agarose gel, ⁇ -carrageenan gel, and the like
- water-insoluble films formed from hydrophilic polymers chitosan film, cellophane, ⁇ -carragheenan cast film, and the like
- a transparent film generally having a thickness of lOO ⁇ m or less from the viewpoint of the shape stability and handling characteristics of the gel sheet, in particular, a water-insoluble film, for example, a chitosan film, cellophane, ⁇ -carragheenan cast film formed from a hydrophilic polymer, and the like are preferable.
- a protective sheet it is preferable to use a polyethylene film, a polypropylene film, a PET film, and the like, in particular, it is preferable to use a polyethylene film having a thickness of 500 ⁇ m or less.
- the thickness of the gel sheet is preferably from 0.4 to 3mm, and more preferably from 0.5 to 2mm from the viewpoint of the shape retentivity and the handling characteristics.
- the thickness of the support layer and the protection sheet is described in the above, in the case of the gel sheet with a multilayered structure formed of a hydrogel layer, and a support layer and/or a protective sheet, the thickness of the support layer is still more preferably from 5 to 80 ⁇ m, and the thickness of the protective sheet is still more preferably from 50 to 500 ⁇ m.
- the thickness of the hydrogel may be the same as that of the thickness of the above-described hydrogel layer, or may suitably be adjusted such that the thickness of the overall gel sheet becomes in the range of from 0.4 to 3mm.
- the gel sheet of the present invention includes, from among the hydrogels including the above described ingredients, a hydrogel formed by combining an O/W type emulsion which includes emulsified particles having an average diameter of from 1 to 150nm, with a polyether compound (polyethers) as an ether-based temperature-sensitive polymer, and with at least one selected from collagen gels or the decomposition products thereof, it is possible to form a gel sheet having particularly superior syneresis.
- the syneresis property for supplying water or the like retained in the gel sheet to the predetermined domain of the adjacent adherend is also important.
- a gel sheet which includes a hydrogel formed by combining an O/W type emulsion containing emulsified particles having an average diameter of from 1 to 150nm, a polyether compound, and collagen and/or the decomposition products thereof, when such a gel sheet contacts water absorptive objects (adherends) such as the skin, the O/W type emulsion containing liposoluble active ingredients is effectively released, and a simultaneous increase in the supply of water content to the keratin layer and the permeability of the active ingredients to the adherend can be obtained.
- the sheet is flexible and easily deformable with stress, and since the surface is in a wet state, adhesion with the adherend may also be enhanced.
- the syneresis in the invention refers to the function of exuding a liquid component (syneresis water) contained in the hydrogel, and moving the syneresis water to a living body or an absorbent body which is an adjacent adherend, due to contact between the gel sheet and the adherend.
- the syneresis water of the gel sheet in the invention contains, in addition to the water content and aqueous-phase components in an emulsion existing in the hydrogel, oil-soluble components or fine solid particles, not only in a water phase, but also in the emulsion particles which exist by being dissolved or dispersed in the liquid component.
- the gel sheet may be referred to as a "high syneresis gel sheet", particularly when a gel sheet is referred to in the context of syneresis.
- the high syneresis gel sheet in the invention can exhibit a syneresis rate of preferably 40% by mass or more, and 90% by mass or less, more preferably 45% by mass or more, and 85% by mass or less, and particularly preferably 50% by mass or more, and 80% by mass or less.
- the syneresis rate in the invention is obtained in such a manner that a gel sheet is cut into a size of 3 cm x 3 cm to form sample gel sheets, and these sample gel sheets are interposed between No.2 filter paper (two kinds of qualitative filter paper stipulated in JIS P3801 (1995 version): 125g/m 2 and 0.26mm in thickness; freeness time: 80 seconds; water absorbency: 80cm), having a diameter of 9cm manufactured by Advantec MSF. Inc., so as to be two sheets of the filter paper for each of the upper and lower sides of the sample gel sheets, and the change of the mass of the filter paper is measured when allowing to stand under the circumstances of 25°C and the relative humidity of 50 ⁇ 10% for 10 minutes.
- the syneresis rate is calculated by the formula (1) shown below using the obtained measured values.
- the "initial mass of gel” is a value obtained by subtracting the mass of the support substrate from the mass of a sample gel sheet test piece.
- the method of measuring the syneresis rate can be referred to, for example, the method described on pages 95-102 of "Fragrance Journal” issued in June, 2007.
- the evaluation of the syneresis rate of the gel sheet based on the amount of liquid absorbed by the filter paper as a water absorptive adherend can be an index whether each component such as water and functional components retained by a hydrogel can permeate into the skin efficiently by being brought a gel sheet into contact with an adherend such as epidermis.
- the syneresis rate is less than 40% by mass, the permeation of water or the like into the skin may become insufficient, and when the syneresis rate exceeds 90% by mass, the stability of a gel sheet during storage may be deteriorated.
- the concentration of the O/W type emulsion particles in the syneresis liquid is preferably a concentration of from 0.001 to 2 times, more preferably from 0.01 to 1.5 times, and most preferably from 0.1 to 1 times the concentration of the O/W type emulsion particles in the hydrogel.
- the concentration of the emulsion particles in the syneresis liquid may be roughly estimated from the concentration measured with a colorimeter by use of the filter paper used in measuring the syneresis rate.
- the concentration of the emulsion particles in the syneresis liquid may be roughly estimated with a spectrophotometer, HPLC or the like after an emulsion or oil-soluble components contained in the emulsion is extracted from the filter paper used in measuring the syneresis rate.
- a spectrophotometer HPLC or the like after an emulsion or oil-soluble components contained in the emulsion is extracted from the filter paper used in measuring the syneresis rate.
- the high syneresis gel sheet can contain an emulsion with fine particles containing oil-soluble active ingredients in the syneresis liquid at high concentrations, so that the active ingredients can efficiently be supplied to an adherend.
- polyether compounds which can be contained in the high syneresis gel sheet for example, polyethylene oxide, polypropylene oxide, polyethylene oxide/polypropylene oxide block copolymer, polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer, and the like can be preferably exemplified, and a block polymer containing polyethylene oxide and polypropylene oxide is particularly preferable, and more specifically, polyethylene oxide/polypropylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO block polymer”), or polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO-PEO block polymer”) is particularly preferable.
- polyethers are known as a poloxamer, and are easily available as commercial products in the trade name of "PLURONIC” and "LUTROL (both are manufactured by BASF A.G.), NEWPOL (manufactured by Sanyo Chemical Industries, Ltd.), and EPAN (manufactured by Dai-Ichi Kogyo Seiyaku Co., Ltd.), PRONON (manufactured by Nippon Oil & Fats Co., Ltd.), and the like.
- the weight average molecular weight (Mw) of the polyethers is preferably from 1,000 to 1,000,000, and more preferably from 5,000 to 500,000.
- the content of the polyether contained in a hydrogel is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferably from 0.2 to 5% by mass.
- the content of the polyether is 0.05% by mass or more in the above-described range, the syneresis can be fully promoted and the effect of an increase in permeation of the active ingredient added in the hydrogel into the skin can be sufficiently achieved, and when the content is 20% by mass or less, a remarkable reduction in the storability can effectively prevented.
- Collagens which can be contained in the high syneresis gel sheet are not specifically limited, but include various collagen extracts. Extraction can be performed using collagen-containing raw materials by known techniques such as acid solubilization, alkali solubilization, neutral salt solubilization and enzyme solubilization. As far as the materials contain collagen, any collagen-containing materials can be used, and the skin, scale, bone, cartilage, tendon, organ, and the like, of vertebrata (for example, cattle, pig, sardine, shark and the like) can be exemplified, and in view of a high content of collagen, bones, cartilage, skins or scale, tendons, placentae and the like can suitably be used.
- vertebrata for example, cattle, pig, sardine, shark and the like
- collagen used suitably in the invention is preferably water-soluble collagen.
- the decomposition products of collagen which can be contained in the high syneresis gel sheet can be obtained by decomposing the collagen with a proteolytic enzyme such as collagenase, trypsin, and chymotrypsin, or by hydrolyzing with an acid or alkali, or by denaturing with heat.
- collagen decomposition products for example, acid-processed gelatin, alkali-processed gelatin, enzyme decomposition gelatin, collagen tripeptide, collagen dipeptide, and amino acids (glycine, proline, hydroxyproline, acetylhydroxyproline and the like) are exemplified.
- the content of the collagen or the decomposition products of collagen contained in the hydrogel in the high syneresis gel sheet is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferably from 0.2 to 5% by mass.
- the content is 0.05% by mass or more, the water retentive effect by adhering the gel sheet to the epidermis can be attained, and when the content is 20% by mass or less, the handling characteristics become good.
- the hydrogel contained in the high syneresis gel sheet is preferably a hydrogel formed by use of an anionic polymer and a water-soluble divalent metal salt, from the viewpoint of improvement of syneresis property, and the content ratio of the water-soluble divalent metal salt is particularly preferable 5 parts by mass or more with respect to 100 parts by mass of the anionic polymer compounds.
- ⁇ Water-soluble Divalent Metal Salt >
- the hydrogel in the gel sheet of the invention contains preferably a water-soluble divalent metal salt.
- the water solubility in the invention refers to a solubility of being at least soluble 0.1% by mass in pure water at 25°C.
- the divalent metal for forming a water-soluble divalent metal salt magnesium, calcium, strontium and barium in the group II of the periodic table, or Cu 2+ , Fe 2+ , Zn 2+ and Mn 2+ in the transition metals are exemplified, and magnesium and calcium are preferable.
- the water-soluble salts may be any of inorganic salts and organic acid salts, and are not specifically limited.
- inorganic salts such as hydrochlorides, nitrates, sulfates, phosphates, carbonates and the like, and organic acid salts such as citrates, lactates, malates, succinates, ascorbates, gluconates, and organic and inorganic composite salts such as ascorbyl phosphate salts, are exemplified.
- magnesium chloride, calcium chloride, magnesium lactate, magnesium malate, magnesium citrate, calcium citrate, magnesium ascorbate, calcium ascorbate, magnesium ascorbyl phosphate, magnesium gluconate, and calcium gluconate are more desirable, and in particular magnesium chloride and magnesium ascorbyl phosphate are preferable.
- the blending amount of the water-soluble divalent metal salt in the high syneresis gel sheet is necessarily 50 parts by mass or more with respect to 100 parts by mass of an anionic polymer compound, which will be described later, (in the present specification, "parts by mass” may be referred to as “parts"), and from the viewpoint of effects, preferably from 50 parts to 1,000 parts, more preferably from 70 parts to 500 parts, and particularly preferably 80 parts to 300 parts.
- the content of the water-soluble divalent metal salt in the blended liquid for forming a hydrogel is preferably from 0.1 to 5% by mass, more preferably from 0.2 to 4% by mass, and particularly preferably from 0.5 to 2% by mass.
- the ratio of the water-soluble metal salt is in this range, the syneresis from the hydrogel can be improved, the gel sheet with excellent handling characteristics can be obtained.
- the water-soluble divalent metal salt is used for formation of a gel, and does not necessarily exist in the state of a "salt.”
- the content of the water soluble divalent metal salt or the compound derived from the metal salt in the formed hydrogel can be obtained by measuring the quantity of the metal for constituting the metal salt, and by converting the obtained quantity.
- the "content of water-soluble divalent metal salt in a hydrogel” refers to the value converted in this manner. According to this method, even after a hydrogel is formed, it is possible to detect as to whether the content of the water-soluble divalent metal salt is within the above range.
- the anionic polymer compounds usable for the high syneresis gel sheet are not specifically limited, and synthetic polymers and natural polymers may be used, as long as the polymer compound contains an anionic group in the molecule selected, for example, from a carboxyl group, a sulfo group, a phospho group and the like.
- anionic polymer compounds may be used singly, or a mixture of two or more may be used in the hydrogel.
- Anionic synthetic polymer compounds include an acrylic acid(co)polymer, a methacrylic acid(co)polymer, a maleic acid(co)polymer, an itaconic acid(co)polymer, p-vinyl benzoic acid(co)polymer, a 2-acrylamide-2-methyl-l-propanesulfonic acid(co)polymer and a styrene sulfonic acid(co)polymer.
- anionic natural polymers compounds include pectic acid, alginic acid, agar, carragheenan, fucoidan, hyaluronic acid, chondroitin sulfate, heparin, gellan gum, native gellan gum, xanthan gum, carboxymethyl cellulose, carboxymethyl starch, carboxymethyl dextran, polyglutamic acid, and further a DNA, RNA and the like.
- an acrylic acid(co)polymer alginic acid, agar, carragheenan, gellan gum, native gellan gum, xanthan gum, carboxymethyl cellulose, carboxymethyl starch, carboxymethyl dextran, polyglutamic acid, and further a DNA, RNA are preferable.
- anionic polymer compounds from the viewpoint of the compatibility of the water retentivity with the gel strength, an acrylic acid(co)polymer, alginic acid, agar, carragheenan, hyaluronic acid, gellan gum, native gellan gum, xanthan gum, carboxymethyl cellulose are preferable, and in particular, agar, carragheenan, gellan gum, native gellan gum, xanthan gum are furthermore preferable.
- the molecular weight of the anionic polymer compounds is preferably within the range of from 10,000 to 5,000,000, and more preferably within the range of from 20,000 to 2,000,000.
- the content of the anionic polymer compound in the hydrogel is preferably from 0.01 to 10% by mass, more preferably from 0.1 to 8% by mass, and particularly preferably from 0.2 to 4% by mass. When the content is within these ranges, a hydrogel with a sufficient syneresis can be obtained, while a high gel strength with good handling characteristics can be achieved.
- the anionic polymer compound and the water-soluble divalent metal salt contained in the hydrogel can be suitably combined in accordance with the intended use, from the viewpoint of compatibility of the gel strength with the syneresis, the combinations of the water-soluble divalent metal salts/anionic polymer compounds can be shown as preferable examples, but the combinations are not limited to these examples: magnesium ascorbyl phosphate /carragheenan; magnesium ascorbyl phosphate /gellan gum; magnesium ascorbyl phosphate /agar; magnesium ascorbyl phosphate /xanthan gum; magnesium ascorbyl phosphate /acrylic acid(co)colymer; magnesium ascorbyl phosphate / carboxymethylcellulose • magnesium chloride /carragheenan, magnesium chloride / gellan gum; magnesium chloride / acrylic acid(co)polymer; magnesium lactate / carragheenan; magnesium lactate / agar; calcium lactate / gellan gum; calcium ascorbate /
- the content of a polyvalent metal salt with trivalence or more in the hydrogel in a high syneresis gel sheet is preferably 0.1% by mass or less, from the viewpoint of prevention of decrease in the syneresis in a blended solution for forming a hydrogel.
- the salts containing polyvalent metal cations such as Al 3+ , Fe 3+ , Ti 3+ , Ti 4+ , In 3+ , Zr 4+ , Ta 5+ and the like are exemplified, and more specifically, potassium alum, ammonium alum, iron alum, aluminum sulfate, polyaluminum chloride, synthetic aluminum silicate, aluminum hydroxide, aluminum stearate, aluminum acetate, ferric sulfate, ferric hydroxide, titanium lactate, zirconium acetate, and the like are exemplified.
- the content of the polyvalent metal salt with trivalence or more in the hydrogel in the high syneresis gel sheet is preferably 0.1% by mass or less in a blended liquid for forming a hydrogel, more preferably 0.05% by mass or less, and particularly preferably 0.01% by mass or less, and most preferably, the hydrogel does not contain such a polyvalent metal salt except for inevitable impurities.
- the content of the trivalent metal salt exceeds 0.1% by mass, there is fear that the syneresis is deteriorated.
- polysaccharides other than the anionic polysaccharide described as examples of the above anionic polymer compounds it is preferable to add polysaccharides other than the anionic polysaccharide described as examples of the above anionic polymer compounds to the hydrogel in order to improve handling characteristics.
- polysaccharides which can be contained in the high syneresis gel sheet for example, neutral polysaccharides (for example, cellulose, amylose, amylopectin, dextran, pullulan, inulin, galactan, mannan, xylan, arabinan, glucomannan, galactomannan, agarose, methyl cellulose, hydroxypropyl cellulose, curdlan, xyloglucan and the like), and cationic polysaccharides (chitin, chitosan, cationized cellulose, cationized starch, cationized dextran and the like, are exemplified.
- neutral polysaccharides for example, cellulose, amylose, amylopectin, dextran, pullulan, inulin, galactan, mannan, xylan, arabinan, glucomannan, galactomannan, agarose, methyl cellulose, hydroxypropyl cellulose, cur
- polysaccharides with a high thickening gelling action is more preferable, and glucomannan, galactomannan, agarose, methylcellulose, hydroxypropyl cellulose are particularly preferable. In order to increasing the gelling properties furthermore, two or more of these polysaccharides may be used in combination.
- the content of the polysaccharides in the hydrogel in the high syneresis gel sheet is preferably from 0.01 to 5% by mass, more preferably from 0.1 to 4% by mass, and particularly preferably from 0.2 to 2% by mass.
- hydrophilic polymers can be added to the hydrogel in order to increase moisture-retaining property, unless the solubility of the gel at the time of adhering the gel sheet to the skin is impaired. Further, the hydrophilic polymer can also be used for improvement of the shape stability of the high syneresis gel sheet.
- hydrophilic polymer which can be contained in the high syneresis gel sheet
- polymer compounds other than the above anionic polymer compound and the polysaccharides may be either synthetic or natural polymer compounds, as long as the polymer compounds have a hydrophilic functional group (for example, a hydroxyl group, a carbamoyl group, an amino group, an ammonio group, an ethyleneoxy group and the like). These polymer compounds may be used singly, or a mixture of two or more may be used.
- the synthetic polymer compounds having such a hydrophilic group for example, a vinyl alcohol(co)polymer, a 2-hydroxyethyl acrylate(co)polymer, an acrylamide(co)polymer, an acryloylmorpholine(co)polymer, an N-vinyl pyrrolidone(co)polymer, a vinyl amine(co)polymer, an N,N-dimethyldiallyl ammonium chloride(co)polymer, 2-methacryloyloxy methyl ammonium chloride(co)polymer, a polyethylene glycol methacrylate(co)polymer, polyethyleneimine, and the like are exemplified.
- a vinyl alcohol(co)polymer for example, a 2-hydroxyethyl acrylate(co)polymer, an acrylamide(co)polymer, an acryloylmorpholine(co)polymer, an N-vinyl pyrrolidone(co
- the weight average molecular weight of the above hydrophilic polymers is preferably from 1,000 to 500,000, and more preferably from 5,000 to 100,000 from the viewpoint of moisture-retaining property. Further, the content of the hydrophilic polymers is preferably from 0.05 to 5% by mass and more preferably from 0.1 to 3% by mass in the hydrogel, from the viewpoint of the moisture-retaining property and handling characteristics.
- Various kinds of active ingredients and additives in accordance with the intended use can also be blended into the high syneresis gel sheet.
- active ingredients and additives for example, in addition to medical properties aiming at the beauty and facial treatments and the skin therapies, a moisturizer, a thickening agent, a fragrance, a colorant, a stabilizer, an antioxidant, an ultraviolet absorber, an adhesive-imparting agent, a pH adjuster, a chelating agent, a surfactant, an antiseptic, an antimicrobial, and the like are exemplified. Regarding these items, the foregoing descriptions can be applicable without modification. [0115] ⁇ Sheet-like Substrate >
- a sheet-like substrate may be provided in the hydrogel layer or adjacent to the hydrogel gel layer.
- the sheet-like substrate is preferably provided in view of an improvement of the shape stability and handling characteristics of the high syneresis gel sheet.
- Materials for forming nonwoven fabrics or textile fabrics are not specifically limited, and fibers generally used are usable, and natural fibers such as cellulose, fibroin and the like, recycled fibers such as rayon and the like, synthetic fibers such as nylon, polyester, polyethylene, polypropylene, acrylic resin, polylactic acid, polyurethane and the like are exemplified, and cellulose, nylon and polyester can suitably be used.
- the textile fabrics or nonwoven fabrics suitably used for a high syneresis gel sheet has a basis weight preferably in the range of from 3g/m 2 to 100g/m 2 , more preferably from
- a sheet-like substrate has a strength with superior handling characteristics, and at the same time, the flexibility of the gel sheet is not deteriorated and the adhesiveness of the gel sheet at the time of adhesion is not reduced.
- the plastic film may be either a liquid impermeable single layer or a multiple-layered plastic sheet, or may be a porous sheet or mesh sheet.
- the thickness of the sheet-like substrate is preferably approximately from 0.01mm to lmm from the viewpoint of the handling characteristics. Further, when used for cosmetic material or the like, a sheet with a high transparency may be preferable as described in this specification.
- a liquid permeable sheet for example, textile fabrics, nonwoven fabrics, porous sheet, mesh sheet and the like are preferable, but, when used as a support on one surface of the hydrogel layer, a liquid impermeable sheet or thick textile fabrics, nonwoven fabrics and the like can be used.
- a substrate such as a polymer gel sheet with a high breakage strength and a hydrophilic polymer film such as a crosslinked gel (gelatin/glutaraldehyde crosslinked gel, polyacrylic acid/polyvalent metal ion crosslinked gel, and the like), and a physical gel (agarose gel, ⁇ -carrageenan gel, and the like), and as well as a water-insoluble film formed from a hydrophilic polymer (chitosan film, cellophane, ⁇ -carragheenan cast film, and the like) and the like can be used.
- a hydrophilic polymer film such as a crosslinked gel (gelatin/glutaraldehyde crosslinked gel, polyacrylic acid/polyvalent metal ion crosslinked gel, and the like), and a physical gel (agarose gel, ⁇ -carrageenan gel, and the like), and as well as a water-insoluble film formed from a hydrophilic polymer (chitosan film, cellophane,
- the high syneresis gel sheet having a structure integrally formed from the hydrogel and textile fabrics or nonwoven fabrics is particularly desirable.
- the integrally formed structure refers to a structure in which a substrate sheet such as textile fabrics, nonwoven fabrics and the like is laminated on at least one surface of the hydrogel layer, and the substrate sheet and the hydrogel layer are adhered to each other so as not to be separated from each other during handling, or a structure in which the substrate sheet is included in the hydrogel layer integrally and indivisibly, and the hydrogel layers are disposed on the both surfaces of the substrate sheet
- the high syneresis gel sheet is preferably provided with a protective sheet on the surface of the gel sheet to be applied to a living body, for the purpose of maintaining active ingredients or water retentivity until the use of the gel sheet.
- a polyethylene film, a polypropylene film, a PET film and the like are preferably used.
- a polyethylene film with a thickness of 500 ⁇ m or less, and more preferably from 20 ⁇ m to 400 ⁇ m is preferably used.
- the thickness of the hydrogel layer in the high syneresis gel sheet is preferably from 0.4mm to 2mm, and particularly preferably from 0.5mm to 1.5mm, generally regardless of the presence of a support, from the viewpoint of the form retentivity and handling characteristics.
- the gel sheet of the invention can be produced in accordance with the methods commonly used.
- the gel sheet when a gel sheet is formed of only a hydrogel, the gel sheet can be manufactured in accordance with the usual method of manufacturing a hydrogel, more specifically, and after a mixed liquid (blended liquid for forming hydrogel) is prepared by heating and mixing components, a gel sheet is formed by means of a coating machine such as a doctor blade and the like. Subsequently, the gel sheet is cooled to accomplish gelation, thereby obtaining the gel sheet.
- a coating machine such as a doctor blade and the like.
- the gel sheet can easily obtained, for example, by laminating by coating a mixed aqueous solution of components for a hydrogel as described in the above on a sheet-like support substrate.
- the polyhydric alcohol, the O/W type emulsion and the polysaccharide may be added in the process of manufacturing the hydrogel, separately or together with one another, or after the manufacture of the hydrogel separately or together with one another.
- a protective sheet in the case of a gel sheet formed from only the hydrogel layer, one surface or both surfaces of the gel sheet may be covered with the protective sheet and in the case of a laminated structure formed of the sheet-like substrate and the hydrogel layer, the protective layer is laminated on the surface, where the sheet-like substrate is not formed, of the gel layer.
- a high transparency of the gel sheet of the invention is preferable in view of relieving seemingly uncomfortable feeling at the time of adhering the gel sheet onto the skin.
- the gel sheet when required to have a high transparency, it is desirable to select the sheet-like substrate or the like, which is used together with the hydrogel layer, having a high light transmittance such as a nylon mesh, a transparent resin film.
- the transparency in the invention can be evaluated on the basis of values evaluated from the transmittance in the wavelength of 600nm with a spectrophotometer.
- the above transparency is desirable a transparency such that the transmittance with reference to distilled water measured by the evaluation method is preferably 60% or more, and more preferably 98% or more.
- the transmittance is 60% or more, it becomes feasible to check the state of the skin at the time of adhesion.
- the gel sheet is not necessarily transparent.
- the water content of the hydrogel in the gel sheet of the invention is desirably 70% by mass or more, and 95 % by mass or less. When the water content is in this range, the releasing efficiency of the active ingredients from the hydrogel is not only improved, but can reduce the irritant property to the epidermis at the time of adhering the gel sheet.
- the water content of the hydrogel is preferably 70% by mass or more and 95% by mass or less, more preferably 75% by mass or more and 95% by mass or less, and particularly preferably 80% by mass or more and 90% by mass or less.
- the water content is less than 70% by mass, the skin permeability of ingredients may decrease, and when the water content exceeds 95% by mass, the handling characteristics may deteriorate due to decrease in the strength of the hydrogel.
- the syneresis gel sheet since the syneresis is excellent, such active ingredients can be efficiently permeated into a predetermined target site of the adherend, for example, a living body and the like by containing various active ingredients in the hydrogel in the range of the preferred water content. Accordingly, the gel sheet of the invention can be suitably used as a sustained-release carrier for the active ingredients or cosmetic materials.
- Ig of a hydrogel taken out from a gel sheet is dried at 25°C under reduced pressure until a mass change of the sample is not observed, and the above water content is given by the value calculated based on the formula (2) as shown below:
- the water content of the hydrogel can be measured from the reduction rate of the mass of the hydrogel due to heat drying or reduced pressure drying. Alternatively, the water content of the hydrogel can be measured with a Carl Fischer type, an infrared ray type, or an electric resistance type aquameter. Further, when a hydrogel blended liquid itself gels, the blending ratio of water may be regarded as the water content of a gel. [0136] Although the form of the gel sheet of the invention is not specifically restricted, the form may be a roll shape formed by winding a tape, or may be an independently separate sheet piece by piece.
- the form is arbitrary and is suitably selected in accordance with the intended use and the body site, for example, an ellipse form, a circular form, a heart form, a semicircle form, a semiellipse form, a square form, a rectangular form, a trapezoidal form, a triangular form, or a combination form thereof, and the like are exemplified, and further, a shape along the pattern of the body site to be applied, or the shape, by which the gel sheet can be most suitably adhered to a body site to be used, may be appropriately designed.
- the gel sheet when used as an adhesive sheet for a living body, an embodiment can be assumed such that a convex portion or a concave portion is formed at a central potion or a peripheral portion of the gel sheet for the purpose of positioning the gel sheet or the like, or a cutoff portion or a cutout portion is formed in accordance with the shape of the body site to be applied, so that the embodiment enables the adhesive sheet to increase in handling characteristics, and to enhance the adhesiveness with an adherend contacting with the sheet in a required domain.
- the body sites of a living body to which the gel sheet of the invention is applied include the face (the lip, gena, eye area, above or under part of eyes, nasal part, forehead, or entire face), the arm part, leg part, chest part, abdomen part, neck part, cephalic part and the like.
- the gel sheet of the invention When the gel sheet of the invention is used as an adhesive sheet for a living body, not only the above-described form, but the area, thickness, adhesiveness of the uppermost surface of the hydrogel layer, and the like are appropriately adjusted according to the body sites. Furthermore, the kind and content of active ingredients to be incorporated into the gel sheet can also suitably be adjusted.
- the form of the adhesive sheet for the face may be divided into two such that an upper part for the forehead, eyes and nasal peripheral part, and the lower part for the oral peripheral part and jaw part are formed.
- gel sheets may be sealed before use in a packaging material made of a gas impermeable material in order to prevent water content and active ingredients from decreasing with time.
- the gel sheet in a continuous tape shape, can be stored in an airtight container, for example, the packing bag formed from a gas impermeable sheet with a zipper, or a container formed from a gas impermeable resin with an openable and closable lid.
- the individual sheet in the case of independently separate sheets piece by piece, may be sealed within an openable individual bag formed from a gas impermeable sheet. Water content and active ingredients can be maintained in a suitable state during storage and distribution until the use of the gel sheet.
- the gel sheet of the invention constituted as described above has an excellent permeability of active ingredients and the like into an adherend and excellent handling characteristics, and is useful for adhesive agents as carriers for percutaneous absorptive medical supplies for administrating drugs to a living body, sheet-like cosmetic materials such as packs used for beauty and facial treatments and skin therapies, carriers for active ingredients such as skin permeable components, antiphlogistic analgetics, adhesive tapes for a living body aimed at the protection against wound or the fixation of drug, and an injury-covering agent, by selecting the kind or amount of ingredients to be contained in the hydrogel layer, the thickness of the hydrogel layer, and the dosage form of the gel sheet.
- the high syneresis gel sheet excels in the adhesiveness to living bodies, moisture-retaining property and the syneresis of active ingredients, and exhibits good handling characteristics, water or active ingredients can be particularly efficiently supplied to an adherend at the time of adhesion, so that the high syneresis gel sheet is suitably used for all uses necessary for continuously supplying water or active ingredients, and excels in biocompatibility and safety, so that in the use of supplying water or active ingredients by applying the gel sheet to living bodies, the effect is remarkable, and can suitably be used as a sustained-release carrier for active ingredients, and cosmetic materials.
- Sheet-like Cosmetic Material [Sheet-like Cosmetic Material]
- the sheet-like cosmetic material of the invention can comprise the gel sheet of the invention. That is, as an active ingredient, a moisturzing ingredient, a skin-whitening ingredient, an astringent ingredient, and the like are held by the gel sheet of the invention to form a cosmetic material.
- This sheet-like cosmetic material is used by bringing the surface of the hydrogel layer into contact with the skin.
- the sheet-like cosmetic material of the invention is particularly useful as a sheet-like cosmetic material for moisturizing the skin or providing the skin with medical properties by adhering the material to the face.
- the sol solution 1 was subjected to a casting to form a thickness of lmm in a case made from polystyrene with a size of 65mm x 95mm, and cooled at 4 0 C for 16 hours to obtain a hydrogel for Example 1.
- the hydrogel was referred to as the gel sheet of Example 1.
- the transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 85%.
- a hydrogel of Example 2 was obtained by a method similar to the manufacturing process of the hydrogel of Example 1 except that PLURONIC F- 127 was replaced with polymethyl vinylether, and the hydrogel of Example 2 was referred to as the gel sheet of Example 2.
- the transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 72%.
- a hydrogel of Example 3 was obtained by a method similar to the manufacturing process of the hydrogel of Example 1 except that PLURONIC F- 127 was replaced with methylcellulose, and the hydrogel of Example 3 was referred to as the gel sheet of Example 3.
- the transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 84%.
- Lecithin (derived from soybean) 9Og The above oil-phase composition was added to the water-phase composition with stirring by means of a homogenizer (10,000rpm), while maintaining at 70°C, and a carotenoid-containing emulsion was obtained.
- the resultant carotenoid-containing emulsion was subjected to a high-pressure emulsification at a pressure of 200MPa using ULTIMIZER HJP-25005 (manufactured by Sugino Machine Limited).
- the volume average particle diameter of the obtained emulsion was measured by a thickened system particle size analyzer FPAR-1000 (Otsuka Electronics Co., Ltd.) at 25°C and the volume average particle diameter of 90nm was obtained.
- the sol-state solution 3 was subjected to a casting to form a thickness of lmm in a case made from polystyrene with a size of 65mm x 95mm, and cooled at 4°C for 16 hours to obtain a hydrogel.
- the hydrogel was referred to as the gel sheet of Comparative Example 1.
- the sol-state solution 4 was subjected to a casting to form a thickness of lmm in a case made from polystyrene with a size of 65mm x 95mm, and cooled at 4 0 C for 16 hours to obtain a hydrogel.
- the hydrogel was referred to as the gel sheet of Comparative Example 2.
- a hydrogel was obtained by a method similar to the manufacturing process of the hydrogel of Example 1 except that PLURONIC F- 127 was replaced with poly (N-isopropylacrylamide).
- the hydrogel was referred to as the gel sheet of Comparative Example 4.
- the gel sheet was stuck for 15 minutes, and after the gel sheet was exfoliated, the amount of the water content in the keratin layer after a lapse of 30 minutes was measured with a keratin layer aquameter (manufactured by Asahibiomed).
- the moisture-retaining property was evaluated in such as manner that in the case that when an increase in the water content was 10% or more at the mean value of the evaluated values by the five graders, the gel sheet was rated at A; in the case that when an increase in the water content was from 2 % to 10%, the gel sheet was rated at B; and in the case that when an increase in the water content was less than 2 %, the gel sheet was rated at C.
- TEWL transepidermal water loss
- a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the transepidermal water loss (TEWL) immediately after exfoliation of the gel sheet on the third day was measured by a transepidermal water loss meter (manufactured by Asahibiomed).
- the skin barrier property was evaluated in such a manner that in the case that when the TEWL value dropped to 5% or more as compared with the value before the test, the gel sheet was rated at A; in the case that when the drop was from 1 to 4%, the gel sheet was rated at B; and in the case that when the TEWL value was not changed, the gel sheet was rated at C.
- Example 5 As shown in Table 1, it is clear that all the gel sheets in Examples 1 - 4 are excellent in the operability, tight fit feeling, moisture-retaining property and skin barrier property. Accordingly, it is clear that the gel sheets having such as excellent effects are also excellent as sheet-like cosmetic materials. [0168] Example 5
- Lecithin (derived from soybean) 9Og The above water-phase composition was added to the oil-phase composition with stirring by means of a homogenizer (10,000rpm), while maintaining at 70°C, and an emulsion was obtained. The resultant emulsion was subjected to a high-pressure emulsification at a pressure of 200MPa using ULTIMIZER HJP-25005 (manufactured by Sugino Machine Limited). The volume average particle diameter of the obtained emulsion was measured by a thickened system particle size analyzer FPAR-1000 (Otsuka Electronics Co., Ltd.) at 25 0 C and the volume average particle diameter of 90nm was obtained.
- the above O/W type emulsion was added to the sol product, and stirred uniformly.
- the hydrogel was covered with a mesh nylon fabric with a basis weight of 20g/m 2 and allowed to stand at 25 °C for 30 minutes so that the gel sheet of Example 5 having the nylon mesh sheet as the sheet-like substrate with hydrogel layers on both surfaces of the substrate was obtained.
- the total thickness of the hydrogel layers was 0.8mm.
- the adhesive gel sheets for living bodies of Examples 5 - 8, and Comparative Examples 5 - 8 were cut into a size of 3cm x 3cm to form sample gel sheets, and these sample gel sheets were interposed between No.2 filter paper manufactured by Advantec MSF. Inc., so as to be two sheets of the filter paper for each of the upper and lower sides of the sample gel sheets, and the change of the mass of the filter paper was measured when allowing to stand under the circumstances of 25°C and the relative humidity of 55% for 10 minutes.
- the syneresis rate was calculated by the formula shown below using the obtained measured values. The test was reiterated five times and the mean values thereof are shown in Table 2.
- the coloration degree of the liquid-absorbed filter paper was estimated in the evaluation of the syneresis rate.
- Astaxanthin contained in the filter paper was extracted in such a manner that 5 parts by mass of water and 4 parts of acetone were added to one part of absorbed liquid in the liquid absorbed filter paper in the evaluations of the syneresis rate.
- 5 parts by mass of water and 4 parts of acetone were added to one part of the blended liquid for forming hydrogel, and the absorbance at 473nm of the resultant extraction liquid was measured by a spectrophotometer (V-630: manufactured by JASCO Corporation), and the content ratio of emulsion in the syneresis liquid was calculated according to the following formula:
- TEWL transepidermal water loss
- a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the transepidermal water loss (TEWL) immediately after exfoliation of the gel sheet on the third day was measured by a transepidermal water loss meter (manufactured by Asahibiomed).
- the skin barrier property was evaluated in such a manner that when the TEWL value dropped to 5% or more as compared with the value before the test, the gel sheet was rated at A; when the drop was from 1 to 4%, the gel sheet was In order to evaluate an improvement function of rough dry skin, the transepidermal water loss (TEWL) was measured by the following methods.
- a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the transepidermal water loss (TEWL) immediately after peeling off the gel sheet on the third day was measured by a transepidermal water loss meter (manufactured by Asahibiomed).
- the skin barrier property was evaluated in such a manner that in the case that when the TEWL value dropped to 5% or more as compared with the value before the test, the gel sheet was rated at A; when the drop was from 1 to 4%, the gel sheet was rated at B; and when the change of the TEWL value was not observed, the gel sheet was rated at C.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention provides the gel sheet comprising a hydrogel which comprises an ether-based temperature-sensitive polymer, and at least one of collagen or decomposition products of collagen; and the sheet-like cosmetic material using the gel sheet described above.
Description
DESCRIPTION
GEL SHEETAND SHEET-LIKE COSMETIC MATERIAL USING THE SAME
TECHNICAL FIELD
[0001] The present invention relates to a gel sheet used in the fields such as pharmaceuticals, quasi-drugs, cosmetics, sanitary materials, and miscellaneous goods, and a sheet-like cosmetic material using the gel sheet. BACKGROUND ART
[0002] Gel sheets are used for a pack material and an adhesive agent used for the beauty and facial treatments and skin therapies; carriers for active ingredients such as a skin permeable component, and an antiphlogistic analgetic; an adhesive tape for living bodies aimed at the protection against wound or the fixation of drug; and an injury-covering agent. These gel sheets protect the surface of the skin by adhering on the surface of the skin, impart a water retentivity to the skin surface, and contain various ingredients in the gel sheet, thereby imparting a water content (water retentivity) and controlling the temperature of the skin, or exhibiting functions for supplying active ingredients in the gel sheet to living bodies. In particular, an increase in the temperature and water content of the skin can promote the migration of active ingredients due to permeation of the active ingredients in a sheet into the skin.
[0003] It has been known that a gel sheet having such a function contains collagen, and polysaccharides such as chitin, chitosan, alginic acicl and cellulose, as a constituent component (for example, see, Japanese patent Application Laid-Open (JP-A) No. 3-81213).
[0004] Meanwhile, as a temperature-sensitive change-of-state hydrogel composition, a technology, in which a drug in a hydrogel is medicated into the skin due to the change of the state from the gel to a flowable state by the body temperature when the hydrogel contacts the skin, has been known (for example, see, Published Japanese Translation of PCT International Publication for Patent Application (JP-T) No. 2007-502269). Further, an adhesive sheet comprising a temperature-responsive polymer having a transition temperature of from 4 to 340C and an adhesive polymer (for example, see, JP-ANo. 5-184657), and a temperature-responsive gel sheet recognized in a temperature-responsive hydrogel formed from a particular polyether ester, (for example, see, JP-ANo. 11-92554) have been known.
However, these gel sheets are insufficient for rapidly medicating active ingredients or the like in a gel, into the skin, and in many cases, the sheets are inferior in handling characteristics.
DISCLOSURE OF INVENTION
[0005] In view of the above circumstances, an object of the present invention is to provide a gel sheet having improved permeability with respect to water or active ingredients upon contacting an adherend such as an epidermis and the like, and excellent handling characteristics, and a sheet-like cosmetic material using the gel sheet. [0006] A first aspect of the invention provides a gel sheet comprising a hydrogel which comprises an ether-based temperature-sensitive polymer, and at least one of collagen or decomposition products of collagen.
A second aspect of the invention provides a sheet- like cosmetic material using any one of the gel sheets described above.
[0007] The invention can provide a gel sheet and a sheet-like cosmetic material using the gel sheet with an improved permeability of water or active ingredients in the sheet by bringing the gel sheet into contact with an adherend such as the epidermis and the like, and excellent handling characteristics.
BEST MODE FOR CARRYING OUT THE INVENTION
[0008] The gel sheet of the present invention contains an ether-based temperature-sensitive polymer, and at least one of collagen and decomposition product thereof.
The ether-based temperature-sensitive polymer of the above gel sheet is preferably at least one selected from the group consisting of polyethers, polyvinyl ethers, and alkylated polysaccharide derivatives, more preferably a block polymer containing polyethylene oxide and polypropylene oxide.
The gel sheet may contain an O/W type emulsion, and the O/W type emulsion may contain a carotenoid.
[0009] Further, the gel sheet of the present invention is preferably those that a syneresis liquid of the gel sheet contains the emulsified particles of the O/W type emulsion.
The gel sheet of the present invention preferably comprises a hydrogel layer containing the hydrogel and a sheet-like substrate provided in the hydrogel layer or adjacent to the hydrogel gel layer.
The invention will be described below.
Any notation for expressing numerical range in the invention indicates a range defined by the minimum and maximum values both inclusive. [0010] In the invention, the "gel sheet" includes gel sheets used for a pack material and
an adhesive agent used for the beauty and facial treatments and skin therapies, carriers for active ingredients such as a skin permeable component, an antiphlogistic analgetic, an adhesive tape for living bodies aimed at the protection against wound or the fixation of drug, and an injury-covering agent, and refers to a sheet which retains active ingredients or water, and is used by directly adhering the sheet to an adherend for the purpose of permeating the retained components to the adherend. The gel sheet is useful as cosmetic materials such as a pack agent for being adhered onto the skin to provide the skin with water or active ingredients. [0011] [Gel sheet]
The gel sheet of the invention contains a gel sheet containing an ether-based temperature-sensitive polymer, and at least one of collagen and decomposition product thereof.
The ether-based temperature-sensitive polymer used in the invention causes the dehydration with an increase in temperature. On the other hand, the conformation of collagen or gelatin which is a decomposition product of collagen varies with an increase in temperature. The combined use of the ether-based temperature-sensitive polymer and collagen or its decomposition product having such properties enables the control of a releasing amount of active ingredients such as medical properties contained in the hydrogel, and the maintenance of an appropriate shape strength of the hydrogel. Accordingly, the gel sheet containing the hydrogel is useful for a sheet-like cosmetic material for providing moisture-retaining property and for permeating active ingredients into the skin. [0012] (Hydrogel) < Ether-based Temperature-Sensitive Polymer >
The hydrogel used for the invention contains an ether-based temperature-sensitive
polymer.
The ether-based temperature-sensitive polymer of the invention refers to a polymer which hydrates at a certain temperature or less in the presence of water, and when this temperature is exceeded, dehydrates and thereby undergoes a conformation change. These microscopic changes induced by the temperature changes appear as macroscopic changes such as a change in volume, a hydrophilic-hydrophobic change, an optical change, a swelling-contraction change and the like.
[0013] The "certain temperature" is referred to as the temperature of the lower critical consolute temperature, and from the viewpoint of an increase in the skin permeability of water or active ingredients when adhering the gel sheet to living bodies, the temperature is preferably from 20 to 40°C, and more preferably from 25 to 30°C. [0014] The ether-based temperature-sensitive polymer used in the invention has the above temperature-sensitive characteristic, and any polymer can be used without limitation as long as the polymer has an ether bond. From the viewpoint of the compatibility of the responsiveness to temperature and the stability during storage, the ether-based temperature-sensitive polymer has preferably a weight average molecular weight (Mw) of from 5,000 to 1,000,000, and more preferably from 10,000 to 500,000.
In particular, from the viewpoint of the responsiveness to the temperature of living bodies and the affinity with a substrate material, at least one of ether-based temperature-sensitive polymers selected from the group consisting of polyethers, vinylethers and alkylated polysaccharide derivatives is preferable, and examples thereof include the following compounds:
[0015] As polyethers, for example, polyethylene oxide, polypropylene oxide, polyethylene oxide/polypropylene oxide block copolymer, polyethylene
oxide/polypropylene oxide/polyethylene oxide block copolymer, and the like can be preferably exemplified.
[0016] As polyvinyl ethers, for example, polymethyl vinylether, polyethyl vinylether, polymethoxyethyl vinylether, polyethoxyethyl polyvinylether, and the like can be preferably exemplified.
[0017] As alkylated polysaccharide derivatives, for example, methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropyl methylcellulose, ethyl cellulose, hydroxypropyl chitosan, and the like can be preferably exemplified. [0018] Further, from the viewpoint of the responsiveness to the temperature of living bodies and the affinity with a substrate material, the polyethers, polyvinylethers and alkylated polysaccharide derivatives have preferably at least one or more functional groups selected from the group consisting of an oxyethylene group, an oxypropylene group, a methoxy group and an ethoxy group, and in the above examples, polyethylene oxide/polypropylene oxide block copolymer, polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer, polymethyl vinylether, methylcellulose, and the like are preferable.
[0019] As the ether-based temperature-sensitive polymer of the invention, a block polymer containing polyethylene oxide and polypropylene oxide is particularly preferable, and more specifically, polyethylene oxide/polypropylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO block polymer"), or polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO-PEO block polymer") is desirable. These polyethers are known as a poloxamer, and are easily available as commercial products, under the trade name of "PLURONIC" and "LUTROL (both are manufactured by BASF A.G.), NEWPOL
(manufactured by Sanyo Chemical Industries, Ltd.), and EPAN (manufactured by Dai-Ichi Kogyo Seiyaku Co., Ltd.), PRONON (manufactured by Nippon Oil & Fats Co., Ltd.), and the like. The above ether-based temperature-sensitive polymer can be used singly, or a mixture of two or more can be used [0018] The content of the ether-based temperature-sensitive polymer in the hydrogel used in the invention is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferably from 0.2 to 5% by mass.
[0020] When the content of the ether-based temperature-sensitive polymer is 0.05% by mass or more, the effect of an increase in permeation of active ingredients added in the hydrogel into the skin can be sufficiently achieved, and when the content is 20% by mass or less, a remarkable reduction in the storability of the hydrogel can prevented. [0021 ] < Collagen and Decomposition Product >
The hydrogel used in the invention includes collagen and the decomposition product thereof.
Collagen herein is not specifically limited, but includes various collagen extracts. Extraction can be performed using collagen-containing raw materials by known techniques such as acid solubilization, alkali solubilization, neutral salt solubilization and enzyme solubilization. As far as the materials contain collagen, any materials can be used, and the skin, scale, bone, gristle, tendon and vertebrata (for example, cattle, pig, sardine, shark and the like) can be exemplified, and in view of a high content of collagen, bones, gristles, skins or scale, tendons, placentae and the like can suitably be used. In particular, collagen used suitably in the invention is preferably water-soluble collagen. The decomposition products of collagen in the invention can be obtained by decomposing the collagen with a proteolytic enzyme such as collagenase, trypsin, and chymotrypsin, or by hydrolyzing with
an acid or an alkali, or by denaturing with heat.
[0022] As collagen decomposition products, for example, acid-processed gelatin, alkali-processed gelatin, enzyme decomposition gelatin, collagen tripeptide, collagen dipeptide, and amino acids (glycine, proline, hydroxyproline, acetylhydroxyproline and the like) are exemplified.
[0023] In the invention, in view of releasing active ingredients, at least one of gelatin or gelatin derivatives is preferable among the collagen and the decomposition products of collagen.
[0024] The gelatin is a hydrolyzed protein of collagen. The production methods of the gelatin are not specifically limited, and the gelatin is commonly manufactured by a acid process or an alkali process from cattle bones, cattle skins, pig skins and fish scale, and the like as raw materials, but may be manufactured by an enzyme method.
[0025] Further, as gelatin derivatives, known derivatives can be used. For example, acid anhydride adducts of gelatin (for example, phthalated gelatin, succinated gelatin, trimellited gelatin and the like), lactone adducts (glucono-δ-lactone adduct gelatin, and the like), acylated gelatin (acetylated gelatin, and the like), esterified gelatin (methylesterified gelatin, and the like), organic acid salt of gelatin (gelatin acetate, gelatin stearate, gelatin benzoate), and the like are exemplified.
[0026] As the gelatin and the derivatives thereof used for the gel sheet of the invention, gelatin derived from pig skin, gelatin derived from fish, succinated gelatin, phthalated gelatin, and trimellited gelatin are desirable from the viewpoint of the affinity with living bodes and the releasing property of active ingredients.
[0027] As the gelatin and the derivatives thereof, a gelatin may be used singly, or a combination of two or more of gelatins may be used, a gelatin derivative may be used
singly, or a combination of two or more of gelatin derivatives may be used, or a mixture of gelatin and gelatin derivatives may be used.
[0028] Furthermore, the weight average molecular weight of the gelatin and gelatin derivative in the invention is preferably from 5,000 to 1,000,000, more preferably from 5,000 to 300,000, and particularly preferable from 10,000 to 300,000, as the weight average molecular weight measured by the gel permeation chromatography (GPC). [0029] The content of the collagen and the decomposition product of collagen contained in the hydrogel in the invention is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferable from 0.2 to 5% by mass. The content of the collagen and decomposition product of collagen of 0.05% by mass or more is effective to the permeability of active ingredients in the hydrogel into the skin, and when the content is 20% by mass or less, the handling characteristics become good.
Furthermore, the mass ratio of the ether-based temperature-sensitive polymer to the collagen and decomposition product thereof (ether-based temperature-sensitive polymer : collagen and decomposition product thereof) is preferably from 1:50 to 50:1, more preferably from 1 : 10 to 10: 1 , and particularly preferably from 1 :5 to 5:1 in view of the permeability of active ingredients into the skin.
[0030] In order to exert various effects, the gel sheet of the invention further contains preferably other components such as polyhydric alcohol compounds, an O/W type emulsion, and polysaccharides, in the hydrogel. Furthermore, a hydrophilic polymer and the like may also be contained, if needed. [0031 ] < Polyhydric Alcohol Compound >
From the viewpoint of the permeability of active ingredients into the skin and the storability, the gel sheet of the invention preferably further contains polyhydric alcohol
compounds.
[0032] The polyhydric alcohol compounds include, specifically, glycerins (glycerin, diglycerin and the like); glycols (for example, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycol, 1,2-propanediol, 1,3 -propanediol, dipropylene glycol, 1,2-butanediol, 1,3-butanediol, 1 ,2-pentanediol, 1,2-hexanediol, 1 ,2-octanediol, and the like), saccharides (glucose, fructose, mannose, galactose, xylose, arabinose, glucosamine, N-acetylglucosamine, sucrose, lactose, maltose, isomaltose, trehalose, cellobiose, kojibiose, sophorose, maltotriose, raffinose, stachyose, and the like), sugar alcohol (glycerol, threitol, erythritol, arabinitol, xylitol, ribitol, mannitol, sorbitol, galactitol, inositol, and the like) are exemplified. The above polyhydric alcohol compound may be used singly, or a mixture of two or more may be used. [0033] Among them, glycerins or glycols are preferably used in the gel sheet of the invention, in particular, glycerin, 1,2-propanediol, 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, and 1,3-butanediol are more desirable. Furthermore, glycerin, 1,2-propanediol, 1,3-butanediol, and 1,2-hexanediol are particularly preferably used. [0034] The ratio of the polyhydric alcohol compounds contained in the hydrogel in the invention is preferably 50% by mass or less, and particularly preferably from 1 to 20 % by mass.
The ratio of the polyhydric alcohol compounds contained in the hydrogel in the invention is preferably 50% by mass or less, thereby preventing reduction in the gel strength, and improving handling characteristics. [0035] < O/W Type Emulsion >
The gel sheet of the invention contains preferably an O/W type emulsion. In particular, an O/W type emulsion containing oil-soluble active ingredients and medicinal
properties is preferable. In this manner, the components in the O/W type emulsion can be supplied to an adherend, so that the function of each component, for example, making the skin beautiful, can be enhanced by the skin permeation.
[0036] As oil-soluble active ingredients, for example, lipid soluble vitamins and their related substances (tocopherol, tocotrienol, retinol, retinal, calciferol, and the like), sterols (cholesterol, phytosterol, and the like), ubiquinones (CoQlO and the like), and a sphingolipid, a ceramide, a oryzanol, a squalene, a squalane, a carotenoid, and the like, and derivatives thereof are still desirable, and in the invention, the carotenoid is especially preferable.
[0037] As the carotenoid, actinioerythrol, astaxanthin, bixin, canthaxanthin, capsanthin, β-8'-apo-carotenal, β-12'-apo-carotenal, α-carotene, β-carotene, γ-carotene, β-cryptoxanthin, lutein, lycopene, violaxantin, zeaxanthin, fucoxanthin, and derivatives thereof are exemplified.
Among them, astaxanthin, lutein, zeaxanthin and β-cryptoxanthin are especially desirable, and astaxanthin, for which an antioxidant effect, an anti-inflammatory effect, an antiaging skin-care effect and a whitening effect are recognized, is particularly desirable. [0038] In addition, other components such as an emulsifier, which can generally be contained in each phase of an emulsion, may be contained in the O/W type emulsion composition in an amount of being generally used. In such other components, other components such as polyhydric alcohols described in the present specification are included.
[0039] The volume average particle diameter of the emulsified particles of the O/W type emulsion, is preferably from lnm to 200nm, more preferably from lnm to 150nm, and particularly preferably from lnm to lOOnm.
[0040] The volume average particle diameter can be measured with a commercial particle size distribution analyzer or the like. As the particle size measuring method of an emulsion, an optical microscopic method, a confocal laser scanning microscopic method, an electron microscopic method, an atomic force microscopic method, a static light scattering method, and a laser diffraction method, a dynamic light scattering method, a centrifugal sedimentation method, an electric pulse measuring method, a chromatographic method, an ultrasonic attenuation method, and the like are known, and apparatuses according to each measuring principle are on the market.
[0041] In view of the range of the volume average particle diameter and the ease of the measurement thereof in the invention, the dynamic light scattering method is desirable for the measurement of the volume average particle diameter of the emulsion in the invention. As the commercial measuring device using the dynamic light scattering method, NANOTRAC UPA (Nikkiso Co., Ltd.) and a dynamic light scattering particle size distribution analyzer LB-550 (Horiba, Ltd.), a thickened system particle size analyzer FPAR-1000 (Otsuka Electronics Co., Ltd.), and the like are exemplified. [0042] In the invention, the values of the volume average particle diameter of the O/W type emulsion measured at 25°C by the thickened system particle size analyzer FPAR-1000 (manufacture by Otsuka Electronics Co., Ltd.), are adopted.
[0043] In the method of measuring the volume average particle diameter, the volume average particle diameter is measured with a measurement glass tube in such a manner that the emulsion is diluted with pure water so that the concentration of the oil phase becomes from 0.1 to 1% by mass. The volume average particle diameter can be obtained as an accumulative value (50%) when the refractive index of the dispersion medium is set to 1.3313 (pure water), and the viscosity of the dispersion medium is set to 0.8846mPa s
(pure water).
[0044] The method of producing the O/W type emulsion is not specifically limited, but, for example, the methods described in JP-A No. 2005-75817 can be used. Alternatively, the OAV type emulsion is preferably produced by a method comprising the steps of (a) forming a water phase prepared by dissolving a water-soluble emulsifier in an aqueous medium, (b) forming an oil phase by mixing and dissolving a carotenoid, a tocopherol, a lecithin, and optionally other oils and fats, and (c) mixing and emulsifying the water phase and the oil phase with stirring.
[0045] When emulsifying, it is particularly preferable that after emulsifying by the use of a usual emulsifying machine utilizing a shearing action with a stirrer, an impeller agitation, a homomixer, and a continuous circulation type shearing machine, the emulsion is further emulsified by being passed through a high pressure homogenizer or the like, so that two or more of emulsifying machines are used in combination. By the use of the high pressure homogenizer, an emulsion containing liquid droplets with a more uniform fine particle size can be obtained.
[0046] The content of the O/W type emulsion in the hydrogel of the invention is preferably from 0.001 to 10% by mass, and more preferably from 0.05 to 1% by mass, from the viewpoint of the effects and permeation of active ingredients into the skin. Further, the content of oil soluble active ingredients in the hydrogel of the invention is preferably from 0.0001 to 10% by mass, and more preferably from 0.05 to 5% by mass, although the content of the oil-soluble active ingredients varies with the kind of the active ingredient.
[0047] When the oil-soluble active ingredient is a carotenoid, the content of the carotenoid in the hydrogel of the invention is preferably from 0.0001 to 0.5% by mass,
more preferably from 0.0005 to 0.1% by mass, and particularly preferably from 0.001 to 0.05% by mass. When the content of the carotenoid is 0.0001% by mass or more, the effects (making the skin beautiful or the like) after adhering the gel sheet of the invention onto the skin are felt, and when the content of the carotenoid is 0.5% by mass or less, unpleasant feelings are not apt to arise due to suppression of coloration of the skin. [0048] < Polysaccharide >
It is desirable that a polysaccharide is added to the gel sheet of the invention for improving the handling characteristics thereof.
The polysaccharides which can be used for the invention, include polysaccharides other than the above ether-based temperature-sensitive polymer, for example, neutral polysaccharides (for example, cellulose, amylose, amylopectin, agarose, dextran, pullulan, inulin, galactan, mannan, xylan, arabinan, glucomannan, galactomannan, and the like), and anionic polysaccharides (pectic acid, alginic acid, agar, carragheenan, fucoidan, hyaluronic acid, a chondroitin sulfate, heparin, gellan gum, native gellan gum, xanthan gum, carboxymethylcellulose, and the like), and cationic polysaccharides (chitin, chitosan, cationic cellulose, and the like).
[0049] Among them, polysaccharides with a high thickening gelling action is more preferable, and glucomannan, galactomannan, agar, carragheenan, gellan gum, native gellan gum, and xanthan gum are particularly preferable. In order to increasing the gelling action, two or more of these polysaccharides are used in combination. [0050] The content of the polysaccharide in the hydrogel of the invention is preferably from 0.01 to 5% by mass, more preferably from 0.1 to 4% by mass, and particularly preferably from 0.2 to 2% by mass. [0051] When the content of polysaccharide is 0.01% by mass or more, the insufficiency
of the gel strength can be suppressed so that handling characteristics become good, and when the content of polysaccharide is 5% by mass or less, the depression of the skin permeability can be prevented. [0052] < Hydrophilic Polymer >
Known hydrophilic polymer can be added to the hydrogel of the gel sheet used for the invention for the purpose of improving a moisture-retaining property or the like, unless the solubility of the gel at the time of adhering the gel sheet to the skin is impaired. Further, the hydrophilic polymers can also be used for improving the shape stability of the gel sheet.
[0053] The hydrophilic polymers which can be used in the invention may be polymer compounds other than the above ether-base temperature-sensitive polymers and the polysaccharides, and may be either synthetic or natural polymer compounds, as long as the polymer compounds have a hydrophilic functional group (for example, a hydroxyl group, a carboxyl group, a sulfo group, a phospho group, a carbamoyl group, an amino group, an ammonio group, an ethyleneoxy group, and the like). These polymer compounds may be used singly, or a mixture of two or more may be used.
[0054] As the synthetic polymer compounds having a hydrophilic group suitable for the invention, for example, anionic polymer compounds such as a vinyl alcohol(co)polymer, a 2-hydroxyethyl acrylate(co)polymer, an acrylic acid(co)polymer, a methacrylic acid(co)polymer, a maleic acid(co)polymer, an itaconic acid(co)polymer, p-vinyl benzoic acid(co)polymer, 2-acrylamide-2-methyl-l-propanesulfonic acid(co)polymer and a styrene sulfonic acid(co)polymer, as well as an acrylamide(co)polymer, an acryloylmorpholine(co)polymer, an N-vinyl pyrrolidone(co)polymer, a vinyl amine(co)polymer, an N,N-dimethyldiallyl ammonium chloride(co)polymer, a
2-methacryloyloxyethyl ammonium chloride(co)polymer, a polyethylene glycol methacrylate(co)polymer, polyethyleneimine, and the like are exemplified. [0055] The weight average molecular weight of the above hydrophilic polymers is preferably from 1,000 to 500,000, and more preferably from 5,000 to 100,000 from the viewpoint of the moisture-retaining property.
Further, the content of the hydrophilic polymers is preferably from 0.05 to 5% by mass and more preferably from 0.1 to 3% by mass in the hydrogel, from the viewpoint of the moisture-retaining property and handling characteristics. [0056] < Excipient >
An excipient may be preferably added to the hydrogel in the invention, for the purpose of further improvement of the shape stability of the gel sheet. As the excipient, organic or inorganic fine particles can suitably be used. As organic fine particles, known polystyrene particles, polymethacrylate particles, and crystallite cellulose are preferable. Further, as inorganic fine particles, silica, alumina, calcium carbonate, kaolin, clay minerals, titanium oxide and the like are desirable. Among them, silica or clay minerals are preferable, and in particular, vapor phase silica and synthetic smectite having an average particle diameter of 200nm or less are particularly preferable.
The ratio of the excipient contained in the hydrogel in the invention is preferably 10% by mass or less, and particularly preferably from 1 to 5% by mass. [0057] < Fragrance >
In order to enhance the effect of relaxation, a fragrance may be added to the hydrogel of the invention. As the fragrance, an alcohol-based fragrance, a phenol-based fragrance, a carboxylic acid-based fragrance, an amine-based fragrance and the like are exemplified. As the alcohol-based fragrance, leaf alcohol, 3-octenol, 9-decenol, linarool,
geraniol, nerol, citronellol, rhodinol, dimethyloctanol, hydroxy citronellol, tetrahydrolinalool, lavandulol, muguol, mycenol, teφineol, 1 -menthol (L-menthol), borneol, isopulegol, tetrahydromuguol, bornylmethoxy cyclohexanol, nobol, farnesol, nerolidol, santalol, sandalol, cedrol, vetiverol, patchouli alcohol, benzyl alcohol, β-phenyl ethylalcohol, γ-phenyl propylalcohol, cinnamic alcohol, anise alcohol, α-amylcinnamic alcohol, dimethylbenzyl carbinol, methylphenyl carbinol, dimethylphenyl carbinol, β-phenylethyldimethyl carbinol, β-phenylethylmethyl ethylcarbinol, phenoxyethyl alcohol, phenyl glycol, t-butylcyclohexanol, and the like are exemplified.
[0058] Further, as phenol-based fragrances, eugenol, vanillin, cypress thiol, and the like, as carboxylic acid-based fragrances, cinnamic acid, phenyl acetic acid, hydrocinnamic acid and the like, and as amine-based fragrances, indole, skatole, 2-methyl tetrahydroquinoline, 6-methylquinoline and the like, are exemplified. [0059] < Antiseptics >
The gel sheet of the invention preferably further contains antiseptics for the purpose of the measure to deterioration by microbes. Antiseptics include, for example, phenol, benzoic acid and the salts thereof, salicylic acid and the salts thereof, p-hydroxybenzoates (methyl paraben, ethyl paraben, propyl paraben, butyl paraben), 2-phenoxyethanol, dehydroacetic acid and the salts thereof, sorbic acid and the salts thereof, alkylamino ethylglycine chloride, triclosan, benzalkonium chloride, ethanol, propanol, butanol, and the like. These compounds may be used singly, but are preferably used in combination. Among them, p-hydroxybenzoates and phenoxy ethanol are particularly preferable.
[0060] The content of the antiseptics in the invention is preferably from 0.01 to 0.5% by mass, more preferably from 0.02 to 0.3% by mass, and particularly preferably from 0.03 to
0.2% by mass.
[0061] < Organic Acid >
The hydrogel of the invention may also further contain an organic acid from the viewpoint of controlling the pH value thereof. Specifically, the organic acid includes acetic acid, α-hydroxy acid (for example, citric acid, lactic acid, gluconic acid, malic acid, succinic acid and the like), ascorbic acid, pyrrolidone carboxylic acid and the like. These compounds may be used singly, or a mixture of two or more may be used. The content of these compounds is preferably from 0.01 to 5% by mass, and more preferably from 0.05 to 2% by mass in the hydrogel. [0062] < Other Active Ingredients >
The gel sheet of the invention may further contain various kinds of active ingredients or additives in accordance with the intended use of the sheet. As such active ingredients or additives, the following compounds are exemplified: antioxidants (tocopherols, dibutyl hydroxytoluene, butyl hydroxyanisol, gallates, flavonoid, tannin, lignan, saponin and the like);
[0063] ultraviolet absorbers (p-methoxy cinnamic acid, octyl p-methoxycinnamate, 2-methoxy-2-hydroxybenzophenone, 2-ethylhexyl-p-dimethylaminobenzoate, and the like); pH adjusters (buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, succinic acid-sodium succinate, and the like); chelating agents (phytic acid, ethylenediamine tetraacetic acid, and the like); [0064] surfactants (polyglycerin fatty acid esters, sucrose fatty acid esters, lecithin, and the like); vitamins (vitamin A, B1, B2, B6, C, D, E, and derivatives thereof, pantothenic acid,
biotin, nicotinic acid amide, vitamin-C ester, and the like);
[0065] amino acids (glycine, trimethyl glycine, pyrrolidone carboxylic acid, serine, carnitine, γ-amino butyric acid, taurine, threonine, asparagine, glutamine, thyrosin, lysine, histidine, arginine, aspartic acid, glutamic acid, ornithine, valine, leucine, and the like); antiphlogistics (glycyrrhitic acid derivatives, glycyrrhetic acid derivatives, salicylic acid derivatives, cypress thiol, zinc oxide, allantoin, and the like);
[0066] moisturizers (urea, casein, soybean peptide, lactobacllus fermentation metabolism products, yeast fermentation metabolism products, honey, lactoferrin, albumin, hydrolyzed elastin, hydrolyzed keratin, hydrolyzed silk, α-hydroxy acid salt (for example, sodium lactate, potassium lactate, potassium gluconate, and the like), sodium pyrrolidone carboxylate, betaine and whey, and the like);
[0067] whitening agents (ascorbic acid glucoside, 3-O-ethyl ascorbic acid, arbutin, hydroquinone, kojic acid, lucinol, tranexamic acid, adenosine- 1 -sodium phosphate, magnolignan, ellagic acid, retinoid, rutin, resolcinol, cysteine, glutathione, linolic acid, and the like);
[0068] various extracts (for example, angelica keiskei extract, persea gratissima (avocado) fruit extract, hydrangea serrata leaf extract, althea extract, arnica extract, aloe extract, prunus armeniaca (apricot) kernel extract, prunus armeniaca (apricot) kernel extract, ginkgo biloba extract, foeniculum vulgare (fennel) extract, turmeric extract, oolong tea extract, rose fruit extract, echinacea angustifolia leaf exract, Scutellaria baicalensis root extract, phellodendron bark extract, coptis japonica root extract, hordeum vulgare seed extract, hypericum perforatum extract, lamium album extract, nasturtium officinale extract, citrus aurantium dulcis (orange) fruit extract, dehydrated seawater, seaweed extract, hydrolyzed elastin, hydrolyzed wheat powder, hydrolyzed silk, chamomilla recutita
(matricaria) extract, daucus carota sativa (carrot) root extract, artemisia capillaris flower extract, glycyrrhiza extract, hibiscus tea extract, pyracantha fortuneana fruit extract, actinidia chinensis (kiwi) fruit extact, cinchona extract, cucumis sativus (cucumber) fruit extract, guanosine, gardenia florida extract, sasa veitchii extract, sophora angustifolia root extract, walnut shell extract, citrus grandis (grapefruit) fruit extract, clematis vitalba leaf extract, chlorella vulgaris extaract, morus alba leaf extract, gentiana lutea extract, black tea extract, yeast extract, arctium lappa root extract, fermented rice bran extract, oryza stiva (rice) germ oil, Symphytum officinale leaf extract, vaccinium vitis-idaea leaf extract, asiasarum root extract, family of bupleurum extract, umbilical cord extract, saponaria officinalis extract, bumboo extract, Crataegus cuneata fruit extract, zanthoxylum fruit extract, corthellus shiitake (mushroom) extract, rehmania root extract, lithospermum erythrorhizone root extract, perilla herb extract, linden flower extract, spiraea ulmaria flower extract, peony root extract, acorus calamus root extract, birch extract, equisetum arvense extract, hedera helix (ivy) extract, Crataegus oxyacantha extract, sambucus nigra flower extract, achillea millefolium extract, mentha piperita (peppermint) leaf extract, salvia officinalis (sage) leaf extract, malva sylvestris (mallow) extract, cnidium officinale root extract, swertia japonica extract, glycine soja (soybean) seed extract, jujube fruit extract, thymus vulgaris (thyme) extract, green tea extract, eugenia caryophyllus (clove) flower extract, Imperata cylindrical extract, citrus unshiu peel extract, Japanese angelica root extract, calendula officinalis flower extract, peach kernel extract, bitter orange peel extract, houttuynia cordata extract, solanum lycopersicum (tomato) extract, fermented soybeans extract, panax ginseng root extract, allium sativum (garlic) extract, rosa canina fruit extract, hibiscus sabdariffa flower extract, ophiopogonis tuber extract, carum petroselinum (parsley) extract, honey, hamamelis virginiana (witch hazel) extract,
parietaria officinalis extract, isodonis japonicus extract, bisabolol, eriobotrya japonica extract, coltsfoot extract, butterbur sprout extract, poria cocos extract, ruscus aculeatus root extract, vitis vinifera (grape) fruit extract, propolis, luffa cylindrica fruit extract, carthamus tinctorius (safϊlower) flower extract, peppermint extract, tilia platyphyllos flower extract, paeonia sufrruticosa root extract, humulus lupulus (hops) extract, pinus sylvestris cone extract, aesculus hippocastanum (horse chestnut) extract, lysichiton camtschatcense extract, sapindus mukurossi peel extract, melissa officinalis (balm mint) leaf extract, prunus persica (peach) leaf extract, centaurea cyanus flower extract, eucalyptus leaf extract, saxifraga sarmentosa extract, citrus junos fruit extract, coix seed extract, mugwort leaf extract, lavandula angustifolia (lavender) extract, pyrus malus (apple) fruit extract, lactuca scariola sativa (lettuce) extract, citrus medica limonum (lemon) extract, astragalus sinicus extract, rosa centifolia flower extract, rosamarinus officinalis (rosemary) leaf extract, anthemis nobilis flower extract, royal jelly extract, iris extract, lilium candidum bulb extract, crocus sativus flower extract, zingiber officinale (ginger) root extract, capsisum tincrure extract, placenta extract, coix lachryma-jobi (Job's tears) seed extract, citrus junos seed extract, vitis vinifera (grape) seed extract, watercress extract, epiphyllum oxpetalum flower extract, white lupin extract, comb extract, and the like;
[0069] activation agents (for example, royal jelly, sensitizer, cholesterol derivatives, and the like); blood circulation accelerators (for example, nonylic acid valenylamide, nicotinic acid benzylester, nicotinic acid β-buthoxy ethyl ester, capsaicin, zingerone, cantharis tincture, ichthammol, tannic acid, α-borneol, tocopherol nicotinate, inositol hexanicotinate, cyclandelate, cinnarizine, trazoline, acetylcholine, verapamil, cepharanthine, γ-orizanol, and the like;
antiseborrheic agents (for example, sulfur, thianthol, and the like), antiinflammatory agents (for example, tranexamic acid, thiotaurine, hypotaurine, εraminocaproic acid, glycyrrhizic acid, β- glycyrrhizic acid, lysozyme chloride, guaiazulene, hydrocortisone, and the like); active ingredients (for example, diisopropylamine dichloroacetate, 4-aminomethyl cyclohexane carboxylic acid, and the like); and,
[0070] further, pyridoxine hydrochloride, nicotinic acid, nicotinic acid derivatives, calcium pantothenate, D-pantothenyl alcohol, acetyl pantothenyl ethylether, isopropyl methylphenol, estradiol, ethynylestradiol, capronium chloride, diphenhydramine hydrochloride,Takanal, camphor, nonylic acid vanillylamide, nonanoic acid vanillylamide, Pirocton-Olamin, glyceryl pentadecanate, 1 -menthol, mononitro guaiacol, resorcin, benzethonium chloride, mexiletine hydrochloride, auxin, female hormone, cantharis tincture, cyclosporin, hydrocortisone, monostearic acid polyoxyethylene sorbitan, peppermint oil, and the like.
Moreover, if administration of medicines to living bodes by the skin permeation is possible, it is also possible to add medicinal properties such as painkillers, tranquilizers, antihypertensives, antibiotics, antihistamines, antimicrobials and the like, to the gel sheet. [0071] One of these active ingredients can be used singly, or a combination of two or more can be used in accordance with the intended use of the gel sheet. The active ingredients contained in the hydrogel according to the invention may further contain the following components. Since these active ingredients and medicinal properties differs in effective dosage depending on the materials thereof, the content of the ingredients and medicinal properties cannot generally be specified, but is generally preferably from 0.001 to 10% by mass, and more preferably from 0.05 to 5% by mass with respect to the total
amount of the hydrogel. Further, similarly, in the case of moisturizers, the content thereof is generally preferably from 0.1 to 10% by mass, and more preferably from 0.5 to 5% by mass with respect to the total amount of the hydrogel. [0072] [Structure of Gel Sheet]
As described above, in the gel sheet of the invention, the hydrogel may be formed in a single layer structure, or may also be formed in a multilayered structure with other layers. Further, a plurality of the hydrogel layers may be provided. Each ingredient as described in the above may be contained in the hydrogel layer, or may be contained in other layers, if possible. Furthermore, when the hydrogel layer is formed of plural layers, each of the ingredients may be contained in the same hydrogel layer, or may be contained in the plural layers, separately. Thus, when the gel sheet of the invention is formed of a plurality of hydrogel layers, the content of the above-described ingredients is the quantity contained in all the layers of the hydrogel layer constituting the gel sheet. [0073] < Sheet-like Substrate >
For the purpose of reinforcing the hydrogel layer and improving the handling characteristics of the gel sheet, a sheet-like substrate may be provided in the hydrogel layer or adjacent to the hydrogel gel layer.
The sheet-like substrate is preferably provided from the viewpoint of the shape stability and handling characteristics of the gel sheet of the invention. As other layers other than the hydrogel layer, for example, a support layer or a protective sheet can be exemplified.
The support layer is preferably provided, from the viewpoint of the shape stability and handling characteristics of the gel sheet of the invention, and the protective sheet is preferably provided, from the viewpoint of protecting the surface of the hydrogel layer
surface until the use of the gel sheet.
[0074] As the support layer, it is preferable to use known sheet-like substrates such as a nonwoven fabrics, textile fabrics or plastic films, crosslinked gels (gelatin/glutaraldehyde crosslinked gel, polyacrylic acid/polyvalent metal ion crosslinked gel, and the like), and physical gels (agarose gel, κ-carrageenan gel, and the like), and as well as water-insoluble films formed from hydrophilic polymers (chitosan film, cellophane, κ-carragheenan cast film, and the like) and the like.
Among them, in the gel sheet of the invention, it is preferable to use a transparent film generally having a thickness of lOOμm or less from the viewpoint of the shape stability and handling characteristics of the gel sheet, in particular, a water-insoluble film, for example, a chitosan film, cellophane, κ-carragheenan cast film formed from a hydrophilic polymer, and the like are preferable.
[0075] Moreover, as a protective sheet, it is preferable to use a polyethylene film, a polypropylene film, a PET film, and the like, in particular, it is preferable to use a polyethylene film having a thickness of 500μm or less.
[0076] When the gel sheet is formed only from a hydrogel layer, in general, the thickness of the gel sheet is preferably from 0.4 to 3mm, and more preferably from 0.5 to 2mm from the viewpoint of the shape retentivity and the handling characteristics.
Further, although the thickness of the support layer and the protection sheet is described in the above, in the case of the gel sheet with a multilayered structure formed of a hydrogel layer, and a support layer and/or a protective sheet, the thickness of the support layer is still more preferably from 5 to 80μm, and the thickness of the protective sheet is still more preferably from 50 to 500μm. In such a multilayered structure, the thickness of the hydrogel may be the same as that of the thickness of the above-described hydrogel
layer, or may suitably be adjusted such that the thickness of the overall gel sheet becomes in the range of from 0.4 to 3mm. [0077] [High Syneresis Gel Sheet]
When the gel sheet of the present invention includes, from among the hydrogels including the above described ingredients, a hydrogel formed by combining an O/W type emulsion which includes emulsified particles having an average diameter of from 1 to 150nm, with a polyether compound (polyethers) as an ether-based temperature-sensitive polymer, and with at least one selected from collagen gels or the decomposition products thereof, it is possible to form a gel sheet having particularly superior syneresis. [0078] In order to rapidly supply the water or the active ingredients contained in the gel sheet to a target region, in addition to the water retentivity of the gel sheet, the syneresis property for supplying water or the like retained in the gel sheet to the predetermined domain of the adjacent adherend is also important. However, known techniques (for example, the techniques described in JP-ANo. 2005-225837, and the techniques described in JP-ANo. 2003-183147), exhibit insufficient syneresis for rapid and efficient permeation of active ingredients contained in the hydrogel into the skin, while maintaining a moisture-retaining property of the skin surface.
[0079] As described in the above, by forming a gel sheet which includes a hydrogel formed by combining an O/W type emulsion containing emulsified particles having an average diameter of from 1 to 150nm, a polyether compound, and collagen and/or the decomposition products thereof, when such a gel sheet contacts water absorptive objects (adherends) such as the skin, the O/W type emulsion containing liposoluble active ingredients is effectively released, and a simultaneous increase in the supply of water content to the keratin layer and the permeability of the active ingredients to the adherend
can be obtained.
Furthermore, with a high syneresis gel sheet, in addition to the high syneresis, the sheet is flexible and easily deformable with stress, and since the surface is in a wet state, adhesion with the adherend may also be enhanced.
[0080] The syneresis in the invention refers to the function of exuding a liquid component (syneresis water) contained in the hydrogel, and moving the syneresis water to a living body or an absorbent body which is an adjacent adherend, due to contact between the gel sheet and the adherend. The syneresis water of the gel sheet in the invention contains, in addition to the water content and aqueous-phase components in an emulsion existing in the hydrogel, oil-soluble components or fine solid particles, not only in a water phase, but also in the emulsion particles which exist by being dissolved or dispersed in the liquid component. As a result, various active ingredients in the gel sheet can be effectively supplied to an adjacent adherend by contacting the gel sheet to the adherend.
In addition, in this specification, the gel sheet may be referred to as a "high syneresis gel sheet", particularly when a gel sheet is referred to in the context of syneresis. [0081] The high syneresis gel sheet in the invention can exhibit a syneresis rate of preferably 40% by mass or more, and 90% by mass or less, more preferably 45% by mass or more, and 85% by mass or less, and particularly preferably 50% by mass or more, and 80% by mass or less.
[0082] The syneresis rate in the invention is obtained in such a manner that a gel sheet is cut into a size of 3 cm x 3 cm to form sample gel sheets, and these sample gel sheets are interposed between No.2 filter paper (two kinds of qualitative filter paper stipulated in JIS P3801 (1995 version): 125g/m2 and 0.26mm in thickness; freeness time: 80 seconds; water absorbency: 80cm), having a diameter of 9cm manufactured by Advantec MSF. Inc., so as
to be two sheets of the filter paper for each of the upper and lower sides of the sample gel sheets, and the change of the mass of the filter paper is measured when allowing to stand under the circumstances of 25°C and the relative humidity of 50±10% for 10 minutes. The syneresis rate is calculated by the formula (1) shown below using the obtained measured values.
Syneresis rate (% by mass) =
(mass of absorbed liquid by filter paper/initial mass of gel) x 100 (1) [0083] In the above formula (1), the "initial mass of gel" is a value obtained by subtracting the mass of the support substrate from the mass of a sample gel sheet test piece. [0084] The method of measuring the syneresis rate can be referred to, for example, the method described on pages 95-102 of "Fragrance Journal" issued in June, 2007. [0085] In the case that the gel sheet of the invention is constituted, for example, as a gel sheet for living bodies, the evaluation of the syneresis rate of the gel sheet based on the amount of liquid absorbed by the filter paper as a water absorptive adherend can be an index whether each component such as water and functional components retained by a hydrogel can permeate into the skin efficiently by being brought a gel sheet into contact with an adherend such as epidermis. When the syneresis rate is less than 40% by mass, the permeation of water or the like into the skin may become insufficient, and when the syneresis rate exceeds 90% by mass, the stability of a gel sheet during storage may be deteriorated.
[0086] Moreover, the concentration of the O/W type emulsion particles in the syneresis liquid is preferably a concentration of from 0.001 to 2 times, more preferably from 0.01 to 1.5 times, and most preferably from 0.1 to 1 times the concentration of the O/W type emulsion particles in the hydrogel.
Here, the concentration of the emulsion particles in the syneresis liquid may be roughly estimated from the concentration measured with a colorimeter by use of the filter paper used in measuring the syneresis rate. Moreover, the concentration of the emulsion particles in the syneresis liquid may be roughly estimated with a spectrophotometer, HPLC or the like after an emulsion or oil-soluble components contained in the emulsion is extracted from the filter paper used in measuring the syneresis rate. [0087] The above-descriptions about various components including various kinds of oil-soluble active ingredients and other additives, and the contents thereof, the methods of manufacturing O/W type emulsions, and the like are applicable, without modification, to the O/W type emulsion contained in the high syneresis gel sheet. Further, similarly, unless the primary intended use of each component is impaired, other components, which can be contained in each of the oil phase and the water phase of an emulsion, may be contained in each phase of the O/W type emulsion.
The high syneresis gel sheet can contain an emulsion with fine particles containing oil-soluble active ingredients in the syneresis liquid at high concentrations, so that the active ingredients can efficiently be supplied to an adherend. [0088] As the polyether compounds which can be contained in the high syneresis gel sheet, for example, polyethylene oxide, polypropylene oxide, polyethylene oxide/polypropylene oxide block copolymer, polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer, and the like can be preferably exemplified, and a block polymer containing polyethylene oxide and polypropylene oxide is particularly preferable, and more specifically, polyethylene oxide/polypropylene oxide block copolymer (hereafter, simply referred to as "PEO-PPO block polymer"), or polyethylene oxide/polypropylene oxide/polyethylene oxide block copolymer (hereafter, simply referred
to as "PEO-PPO-PEO block polymer") is particularly preferable. These polyethers are known as a poloxamer, and are easily available as commercial products in the trade name of "PLURONIC" and "LUTROL (both are manufactured by BASF A.G.), NEWPOL (manufactured by Sanyo Chemical Industries, Ltd.), and EPAN (manufactured by Dai-Ichi Kogyo Seiyaku Co., Ltd.), PRONON (manufactured by Nippon Oil & Fats Co., Ltd.), and the like.
In this case, the weight average molecular weight (Mw) of the polyethers is preferably from 1,000 to 1,000,000, and more preferably from 5,000 to 500,000. [0089] In the high syneresis gel sheet, the content of the polyether contained in a hydrogel is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferably from 0.2 to 5% by mass. When the content of the polyether is 0.05% by mass or more in the above-described range, the syneresis can be fully promoted and the effect of an increase in permeation of the active ingredient added in the hydrogel into the skin can be sufficiently achieved, and when the content is 20% by mass or less, a remarkable reduction in the storability can effectively prevented. [0090] Collagens which can be contained in the high syneresis gel sheet are not specifically limited, but include various collagen extracts. Extraction can be performed using collagen-containing raw materials by known techniques such as acid solubilization, alkali solubilization, neutral salt solubilization and enzyme solubilization. As far as the materials contain collagen, any collagen-containing materials can be used, and the skin, scale, bone, cartilage, tendon, organ, and the like, of vertebrata (for example, cattle, pig, sardine, shark and the like) can be exemplified, and in view of a high content of collagen, bones, cartilage, skins or scale, tendons, placentae and the like can suitably be used. In particular, collagen used suitably in the invention is preferably water-soluble collagen.
The decomposition products of collagen which can be contained in the high syneresis gel sheet can be obtained by decomposing the collagen with a proteolytic enzyme such as collagenase, trypsin, and chymotrypsin, or by hydrolyzing with an acid or alkali, or by denaturing with heat.
[0091] As the collagen decomposition products, for example, acid-processed gelatin, alkali-processed gelatin, enzyme decomposition gelatin, collagen tripeptide, collagen dipeptide, and amino acids (glycine, proline, hydroxyproline, acetylhydroxyproline and the like) are exemplified.
The content of the collagen or the decomposition products of collagen contained in the hydrogel in the high syneresis gel sheet is preferably from 0.05 to 20% by mass, more preferably from 0.1 to 10% by mass, and particularly preferably from 0.2 to 5% by mass. When the content is 0.05% by mass or more, the water retentive effect by adhering the gel sheet to the epidermis can be attained, and when the content is 20% by mass or less, the handling characteristics become good.
[0092] The hydrogel contained in the high syneresis gel sheet is preferably a hydrogel formed by use of an anionic polymer and a water-soluble divalent metal salt, from the viewpoint of improvement of syneresis property, and the content ratio of the water-soluble divalent metal salt is particularly preferable 5 parts by mass or more with respect to 100 parts by mass of the anionic polymer compounds. [0093] < Water-soluble Divalent Metal Salt >
The hydrogel in the gel sheet of the invention contains preferably a water-soluble divalent metal salt. Here, the water solubility in the invention refers to a solubility of being at least soluble 0.1% by mass in pure water at 25°C.
As the divalent metal for forming a water-soluble divalent metal salt, magnesium,
calcium, strontium and barium in the group II of the periodic table, or Cu2+, Fe2+, Zn2+ and Mn2+ in the transition metals are exemplified, and magnesium and calcium are preferable. [0094] The water-soluble salts may be any of inorganic salts and organic acid salts, and are not specifically limited. For example, inorganic salts such as hydrochlorides, nitrates, sulfates, phosphates, carbonates and the like, and organic acid salts such as citrates, lactates, malates, succinates, ascorbates, gluconates, and organic and inorganic composite salts such as ascorbyl phosphate salts, are exemplified.
[0095] Among them, magnesium chloride, calcium chloride, magnesium lactate, magnesium malate, magnesium citrate, calcium citrate, magnesium ascorbate, calcium ascorbate, magnesium ascorbyl phosphate, magnesium gluconate, and calcium gluconate are more desirable, and in particular magnesium chloride and magnesium ascorbyl phosphate are preferable.
[0096] The blending amount of the water-soluble divalent metal salt in the high syneresis gel sheet is necessarily 50 parts by mass or more with respect to 100 parts by mass of an anionic polymer compound, which will be described later, (in the present specification, "parts by mass" may be referred to as "parts"), and from the viewpoint of effects, preferably from 50 parts to 1,000 parts, more preferably from 70 parts to 500 parts, and particularly preferably 80 parts to 300 parts.
Further, the content of the water-soluble divalent metal salt in the blended liquid for forming a hydrogel is preferably from 0.1 to 5% by mass, more preferably from 0.2 to 4% by mass, and particularly preferably from 0.5 to 2% by mass. When the ratio of the water-soluble metal salt is in this range, the syneresis from the hydrogel can be improved, the gel sheet with excellent handling characteristics can be obtained. [0097] In the hydrogel formed from an anionic polymer and a water-soluble divalent
metal salt, the water-soluble divalent metal salt is used for formation of a gel, and does not necessarily exist in the state of a "salt." However, the content of the water soluble divalent metal salt or the compound derived from the metal salt in the formed hydrogel can be obtained by measuring the quantity of the metal for constituting the metal salt, and by converting the obtained quantity. Accordingly, the "content of water-soluble divalent metal salt in a hydrogel" refers to the value converted in this manner. According to this method, even after a hydrogel is formed, it is possible to detect as to whether the content of the water-soluble divalent metal salt is within the above range. [0098] < Anionic Polymer Compound >
The anionic polymer compounds usable for the high syneresis gel sheet are not specifically limited, and synthetic polymers and natural polymers may be used, as long as the polymer compound contains an anionic group in the molecule selected, for example, from a carboxyl group, a sulfo group, a phospho group and the like.
Only one of these anionic polymer compounds may be used singly, or a mixture of two or more may be used in the hydrogel.
[0099] Anionic synthetic polymer compounds include an acrylic acid(co)polymer, a methacrylic acid(co)polymer, a maleic acid(co)polymer, an itaconic acid(co)polymer, p-vinyl benzoic acid(co)polymer, a 2-acrylamide-2-methyl-l-propanesulfonic acid(co)polymer and a styrene sulfonic acid(co)polymer.
Further, anionic natural polymers compounds include pectic acid, alginic acid, agar, carragheenan, fucoidan, hyaluronic acid, chondroitin sulfate, heparin, gellan gum, native gellan gum, xanthan gum, carboxymethyl cellulose, carboxymethyl starch, carboxymethyl dextran, polyglutamic acid, and further a DNA, RNA and the like. [0100] Among them, an acrylic acid(co)polymer, alginic acid, agar, carragheenan, gellan
gum, native gellan gum, xanthan gum, carboxymethyl cellulose, carboxymethyl starch, carboxymethyl dextran, polyglutamic acid, and further a DNA, RNA are preferable. [0101] In particular, as anionic polymer compounds, from the viewpoint of the compatibility of the water retentivity with the gel strength, an acrylic acid(co)polymer, alginic acid, agar, carragheenan, hyaluronic acid, gellan gum, native gellan gum, xanthan gum, carboxymethyl cellulose are preferable, and in particular, agar, carragheenan, gellan gum, native gellan gum, xanthan gum are furthermore preferable. [0102] From the viewpoint of the gel strength, the molecular weight of the anionic polymer compounds is preferably within the range of from 10,000 to 5,000,000, and more preferably within the range of from 20,000 to 2,000,000.
[0103] In the high syneresis gel sheet, the content of the anionic polymer compound in the hydrogel is preferably from 0.01 to 10% by mass, more preferably from 0.1 to 8% by mass, and particularly preferably from 0.2 to 4% by mass. When the content is within these ranges, a hydrogel with a sufficient syneresis can be obtained, while a high gel strength with good handling characteristics can be achieved.
[0104] By using an anionic polymer and a divalent metal water-soluble salt together in combination, a three-dimensional network structure having a weak crosslinked structure is formed in the hydrogel system to be formed, thus it is considered that a sufficient liquid retentivity and an excellent syneresis develop.
[0105] Although the anionic polymer compound and the water-soluble divalent metal salt contained in the hydrogel can be suitably combined in accordance with the intended use, from the viewpoint of compatibility of the gel strength with the syneresis, the combinations of the water-soluble divalent metal salts/anionic polymer compounds can be shown as preferable examples, but the combinations are not limited to these examples:
magnesium ascorbyl phosphate /carragheenan; magnesium ascorbyl phosphate /gellan gum; magnesium ascorbyl phosphate /agar; magnesium ascorbyl phosphate /xanthan gum; magnesium ascorbyl phosphate /acrylic acid(co)colymer; magnesium ascorbyl phosphate / carboxymethylcellulose • magnesium chloride /carragheenan, magnesium chloride / gellan gum; magnesium chloride / acrylic acid(co)polymer; magnesium lactate / carragheenan; magnesium lactate / agar; calcium lactate / gellan gum; calcium ascorbate /carragheenan; and calcium gluconate / gellan gum. [0106] < Polyvalent Metal Salt with Trivalence or More >
The content of a polyvalent metal salt with trivalence or more in the hydrogel in a high syneresis gel sheet is preferably 0.1% by mass or less, from the viewpoint of prevention of decrease in the syneresis in a blended solution for forming a hydrogel.
As the polyvalent metal salt with trivalence or more, the salts containing polyvalent metal cations such as Al3+, Fe3+, Ti3+, Ti4+, In3+, Zr4+, Ta5+ and the like are exemplified, and more specifically, potassium alum, ammonium alum, iron alum, aluminum sulfate, polyaluminum chloride, synthetic aluminum silicate, aluminum hydroxide, aluminum stearate, aluminum acetate, ferric sulfate, ferric hydroxide, titanium lactate, zirconium acetate, and the like are exemplified.
[0107] The content of the polyvalent metal salt with trivalence or more in the hydrogel in the high syneresis gel sheet is preferably 0.1% by mass or less in a blended liquid for forming a hydrogel, more preferably 0.05% by mass or less, and particularly preferably 0.01% by mass or less, and most preferably, the hydrogel does not contain such a polyvalent metal salt except for inevitable impurities. When the content of the trivalent metal salt exceeds 0.1% by mass, there is fear that the syneresis is deteriorated. [0108] < Polysaccharide >
In the high syneresis gel sheet, it is preferable to add polysaccharides other than the anionic polysaccharide described as examples of the above anionic polymer compounds to the hydrogel in order to improve handling characteristics.
To this end, as polysaccharides which can be contained in the high syneresis gel sheet, for example, neutral polysaccharides (for example, cellulose, amylose, amylopectin, dextran, pullulan, inulin, galactan, mannan, xylan, arabinan, glucomannan, galactomannan, agarose, methyl cellulose, hydroxypropyl cellulose, curdlan, xyloglucan and the like), and cationic polysaccharides (chitin, chitosan, cationized cellulose, cationized starch, cationized dextran and the like, are exemplified.
[0109] Among them, polysaccharides with a high thickening gelling action is more preferable, and glucomannan, galactomannan, agarose, methylcellulose, hydroxypropyl cellulose are particularly preferable. In order to increasing the gelling properties furthermore, two or more of these polysaccharides may be used in combination. [0110] The content of the polysaccharides in the hydrogel in the high syneresis gel sheet is preferably from 0.01 to 5% by mass, more preferably from 0.1 to 4% by mass, and particularly preferably from 0.2 to 2% by mass. If the content of the polysaccharides is in the above range, the improvement effect of the gel strength is attained, and handling
characteristics are good, the syneresis and decrease in the permeability into the skin, and the like can be prevented. [0111] < Hydrophilic Polymer >
In the high syneresis gel sheet, known hydrophilic polymers can be added to the hydrogel in order to increase moisture-retaining property, unless the solubility of the gel at the time of adhering the gel sheet to the skin is impaired. Further, the hydrophilic polymer can also be used for improvement of the shape stability of the high syneresis gel sheet.
[0112] As the hydrophilic polymer which can be contained in the high syneresis gel sheet, polymer compounds other than the above anionic polymer compound and the polysaccharides, may be either synthetic or natural polymer compounds, as long as the polymer compounds have a hydrophilic functional group (for example, a hydroxyl group, a carbamoyl group, an amino group, an ammonio group, an ethyleneoxy group and the like). These polymer compounds may be used singly, or a mixture of two or more may be used. [0113] As the synthetic polymer compounds having such a hydrophilic group, for example, a vinyl alcohol(co)polymer, a 2-hydroxyethyl acrylate(co)polymer, an acrylamide(co)polymer, an acryloylmorpholine(co)polymer, an N-vinyl pyrrolidone(co)polymer, a vinyl amine(co)polymer, an N,N-dimethyldiallyl ammonium chloride(co)polymer, 2-methacryloyloxy methyl ammonium chloride(co)polymer, a polyethylene glycol methacrylate(co)polymer, polyethyleneimine, and the like are exemplified.
The weight average molecular weight of the above hydrophilic polymers is preferably from 1,000 to 500,000, and more preferably from 5,000 to 100,000 from the viewpoint of moisture-retaining property.
Further, the content of the hydrophilic polymers is preferably from 0.05 to 5% by mass and more preferably from 0.1 to 3% by mass in the hydrogel, from the viewpoint of the moisture-retaining property and handling characteristics.
[0114] Various kinds of active ingredients and additives in accordance with the intended use can also be blended into the high syneresis gel sheet. As such active ingredients and additives, for example, in addition to medical properties aiming at the beauty and facial treatments and the skin therapies, a moisturizer, a thickening agent, a fragrance, a colorant, a stabilizer, an antioxidant, an ultraviolet absorber, an adhesive-imparting agent, a pH adjuster, a chelating agent, a surfactant, an antiseptic, an antimicrobial, and the like are exemplified. Regarding these items, the foregoing descriptions can be applicable without modification. [0115] < Sheet-like Substrate >
In the high syneresis gel sheet, for the purpose of reinforcing the hydrogel layer and improving the handling characteristics of the gel sheet, a sheet-like substrate may be provided in the hydrogel layer or adjacent to the hydrogel gel layer. The sheet-like substrate is preferably provided in view of an improvement of the shape stability and handling characteristics of the high syneresis gel sheet.
[0116] In the high syneresis gel sheet, when a sheet-like substrate is used as a support layer, known sheet-like substrate materials such as nonwoven fabrics, textile fabrics and plastic films can be used.
Materials for forming nonwoven fabrics or textile fabrics are not specifically limited, and fibers generally used are usable, and natural fibers such as cellulose, fibroin and the like, recycled fibers such as rayon and the like, synthetic fibers such as nylon, polyester, polyethylene, polypropylene, acrylic resin, polylactic acid, polyurethane and the
like are exemplified, and cellulose, nylon and polyester can suitably be used.
[0117] The textile fabrics or nonwoven fabrics suitably used for a high syneresis gel sheet has a basis weight preferably in the range of from 3g/m2 to 100g/m2, more preferably from
5g/m2 to 70g/m2, and particularly from 5g/m2 to 50g/m2. In this range of the basis weight, a sheet-like substrate has a strength with superior handling characteristics, and at the same time, the flexibility of the gel sheet is not deteriorated and the adhesiveness of the gel sheet at the time of adhesion is not reduced.
[0118] When a plastic film is used, the plastic film may be either a liquid impermeable single layer or a multiple-layered plastic sheet, or may be a porous sheet or mesh sheet.
The thickness of the sheet-like substrate is preferably approximately from 0.01mm to lmm from the viewpoint of the handling characteristics. Further, when used for cosmetic material or the like, a sheet with a high transparency may be preferable as described in this specification.
[0119] When the sheet-like substrate is used in a hydrogel layer, a liquid permeable sheet, for example, textile fabrics, nonwoven fabrics, porous sheet, mesh sheet and the like are preferable, but, when used as a support on one surface of the hydrogel layer, a liquid impermeable sheet or thick textile fabrics, nonwoven fabrics and the like can be used. [0120] Further, when the sheet-like substrate is used as a reinforcing layer for the hydrogel layer, a substrate such as a polymer gel sheet with a high breakage strength and a hydrophilic polymer film such as a crosslinked gel (gelatin/glutaraldehyde crosslinked gel, polyacrylic acid/polyvalent metal ion crosslinked gel, and the like), and a physical gel (agarose gel, κ-carrageenan gel, and the like), and as well as a water-insoluble film formed from a hydrophilic polymer (chitosan film, cellophane, κ-carragheenan cast film, and the like) and the like can be used.
[0121] Among them, the high syneresis gel sheet having a structure integrally formed from the hydrogel and textile fabrics or nonwoven fabrics is particularly desirable. Here, the integrally formed structure refers to a structure in which a substrate sheet such as textile fabrics, nonwoven fabrics and the like is laminated on at least one surface of the hydrogel layer, and the substrate sheet and the hydrogel layer are adhered to each other so as not to be separated from each other during handling, or a structure in which the substrate sheet is included in the hydrogel layer integrally and indivisibly, and the hydrogel layers are disposed on the both surfaces of the substrate sheet
[0122] The high syneresis gel sheet is preferably provided with a protective sheet on the surface of the gel sheet to be applied to a living body, for the purpose of maintaining active ingredients or water retentivity until the use of the gel sheet.
As the protective sheet, a polyethylene film, a polypropylene film, a PET film and the like are preferably used. In particular, a polyethylene film with a thickness of 500μm or less, and more preferably from 20μm to 400μm is preferably used. [0123] The thickness of the hydrogel layer in the high syneresis gel sheet is preferably from 0.4mm to 2mm, and particularly preferably from 0.5mm to 1.5mm, generally regardless of the presence of a support, from the viewpoint of the form retentivity and handling characteristics. [0124] [Production Method of Gel Sheet]
The gel sheet of the invention can be produced in accordance with the methods commonly used.
For example, when a gel sheet is formed of only a hydrogel, the gel sheet can be manufactured in accordance with the usual method of manufacturing a hydrogel, more specifically, and after a mixed liquid (blended liquid for forming hydrogel) is prepared by
heating and mixing components, a gel sheet is formed by means of a coating machine such as a doctor blade and the like. Subsequently, the gel sheet is cooled to accomplish gelation, thereby obtaining the gel sheet.
[0125] In the case of a gel sheet having a support layer, the gel sheet can easily obtained, for example, by laminating by coating a mixed aqueous solution of components for a hydrogel as described in the above on a sheet-like support substrate.
[0126] Further, the polyhydric alcohol, the O/W type emulsion and the polysaccharide may be added in the process of manufacturing the hydrogel, separately or together with one another, or after the manufacture of the hydrogel separately or together with one another.
[0127] Furthermore, when a protective sheet is formed, in the case of a gel sheet formed from only the hydrogel layer, one surface or both surfaces of the gel sheet may be covered with the protective sheet and in the case of a laminated structure formed of the sheet-like substrate and the hydrogel layer, the protective layer is laminated on the surface, where the sheet-like substrate is not formed, of the gel layer.
[0128] [Physical Properties of Gel Sheet]
A high transparency of the gel sheet of the invention is preferable in view of relieving seemingly uncomfortable feeling at the time of adhering the gel sheet onto the skin.
Further, when the gel sheet is required to have a high transparency, it is desirable to select the sheet-like substrate or the like, which is used together with the hydrogel layer, having a high light transmittance such as a nylon mesh, a transparent resin film. [0129] The transparency in the invention can be evaluated on the basis of values evaluated from the transmittance in the wavelength of 600nm with a spectrophotometer.
The above transparency is desirable a transparency such that the transmittance with reference to distilled water measured by the evaluation method is preferably 60% or more, and more preferably 98% or more.
[0130] When the transmittance is 60% or more, it becomes feasible to check the state of the skin at the time of adhesion. However, in the case of adhering the gel sheet onto a body site where seeming is unconcerned, the gel sheet is not necessarily transparent. [0131] The water content of the hydrogel in the gel sheet of the invention is desirably 70% by mass or more, and 95 % by mass or less. When the water content is in this range, the releasing efficiency of the active ingredients from the hydrogel is not only improved, but can reduce the irritant property to the epidermis at the time of adhering the gel sheet. [0132] The water content of the hydrogel is preferably 70% by mass or more and 95% by mass or less, more preferably 75% by mass or more and 95% by mass or less, and particularly preferably 80% by mass or more and 90% by mass or less. When the water content is less than 70% by mass, the skin permeability of ingredients may decrease, and when the water content exceeds 95% by mass, the handling characteristics may deteriorate due to decrease in the strength of the hydrogel.
[0133] In particular, in the case of the above syneresis gel sheet, since the syneresis is excellent, such active ingredients can be efficiently permeated into a predetermined target site of the adherend, for example, a living body and the like by containing various active ingredients in the hydrogel in the range of the preferred water content. Accordingly, the gel sheet of the invention can be suitably used as a sustained-release carrier for the active ingredients or cosmetic materials.
[0134] More specifically, Ig of a hydrogel taken out from a gel sheet, is dried at 25°C under reduced pressure until a mass change of the sample is not observed, and the above
water content is given by the value calculated based on the formula (2) as shown below:
Water content (%) =
[(initial mass - mass after drying)/initial mass] x 100 (2)
[0135] The water content of the hydrogel can be measured from the reduction rate of the mass of the hydrogel due to heat drying or reduced pressure drying. Alternatively, the water content of the hydrogel can be measured with a Carl Fischer type, an infrared ray type, or an electric resistance type aquameter. Further, when a hydrogel blended liquid itself gels, the blending ratio of water may be regarded as the water content of a gel. [0136] Although the form of the gel sheet of the invention is not specifically restricted, the form may be a roll shape formed by winding a tape, or may be an independently separate sheet piece by piece. In the case of an individual sheet, the form is arbitrary and is suitably selected in accordance with the intended use and the body site, for example, an ellipse form, a circular form, a heart form, a semicircle form, a semiellipse form, a square form, a rectangular form, a trapezoidal form, a triangular form, or a combination form thereof, and the like are exemplified, and further, a shape along the pattern of the body site to be applied, or the shape, by which the gel sheet can be most suitably adhered to a body site to be used, may be appropriately designed.
[0137] For example, when the gel sheet is used as an adhesive sheet for a living body, an embodiment can be assumed such that a convex portion or a concave portion is formed at a central potion or a peripheral portion of the gel sheet for the purpose of positioning the gel sheet or the like, or a cutoff portion or a cutout portion is formed in accordance with the shape of the body site to be applied, so that the embodiment enables the adhesive sheet to increase in handling characteristics, and to enhance the adhesiveness with an adherend contacting with the sheet in a required domain.
[0138] The body sites of a living body to which the gel sheet of the invention is applied include the face (the lip, gena, eye area, above or under part of eyes, nasal part, forehead, or entire face), the arm part, leg part, chest part, abdomen part, neck part, cephalic part and the like.
When the gel sheet of the invention is used as an adhesive sheet for a living body, not only the above-described form, but the area, thickness, adhesiveness of the uppermost surface of the hydrogel layer, and the like are appropriately adjusted according to the body sites. Furthermore, the kind and content of active ingredients to be incorporated into the gel sheet can also suitably be adjusted.
[0139] For example, when an adhesive sheet for a living body for the entire face as a body site, to which the adhesive sheet is applied, is formed, it is preferable to make adjustments such that the shape in which the portions corresponding to the positions of the eyes and mouth are cut out, and the portion corresponding to the position of the nasal part is cut off, and further, the adhesiveness of the adhesive layer is increased or the thickness of the gel sheet is reduced suitable for a larger area to be adhered. Moreover, the form of the adhesive sheet for the face may be divided into two such that an upper part for the forehead, eyes and nasal peripheral part, and the lower part for the oral peripheral part and jaw part are formed.
[0140] These gel sheets may be sealed before use in a packaging material made of a gas impermeable material in order to prevent water content and active ingredients from decreasing with time.
For example, in the case of the gel sheet in a continuous tape shape, the gel sheet can be stored in an airtight container, for example, the packing bag formed from a gas impermeable sheet with a zipper, or a container formed from a gas impermeable resin with
an openable and closable lid. Moreover, in the case of independently separate sheets piece by piece, the individual sheet may be sealed within an openable individual bag formed from a gas impermeable sheet. Water content and active ingredients can be maintained in a suitable state during storage and distribution until the use of the gel sheet. [0141] The gel sheet of the invention constituted as described above has an excellent permeability of active ingredients and the like into an adherend and excellent handling characteristics, and is useful for adhesive agents as carriers for percutaneous absorptive medical supplies for administrating drugs to a living body, sheet-like cosmetic materials such as packs used for beauty and facial treatments and skin therapies, carriers for active ingredients such as skin permeable components, antiphlogistic analgetics, adhesive tapes for a living body aimed at the protection against wound or the fixation of drug, and an injury-covering agent, by selecting the kind or amount of ingredients to be contained in the hydrogel layer, the thickness of the hydrogel layer, and the dosage form of the gel sheet. [0142] Since the high syneresis gel sheet excels in the adhesiveness to living bodies, moisture-retaining property and the syneresis of active ingredients, and exhibits good handling characteristics, water or active ingredients can be particularly efficiently supplied to an adherend at the time of adhesion, so that the high syneresis gel sheet is suitably used for all uses necessary for continuously supplying water or active ingredients, and excels in biocompatibility and safety, so that in the use of supplying water or active ingredients by applying the gel sheet to living bodies, the effect is remarkable, and can suitably be used as a sustained-release carrier for active ingredients, and cosmetic materials. [0143] [Sheet-like Cosmetic Material]
The sheet-like cosmetic material of the invention can comprise the gel sheet of the invention.
That is, as an active ingredient, a moisturzing ingredient, a skin-whitening ingredient, an astringent ingredient, and the like are held by the gel sheet of the invention to form a cosmetic material. This sheet-like cosmetic material is used by bringing the surface of the hydrogel layer into contact with the skin.
[0144] Since the adhesive gel sheet for living bodies of the invention is excellent in the permeability of the active ingredients and the like to the skin, and the handling characteristics, the sheet-like cosmetic material of the invention is particularly useful as a sheet-like cosmetic material for moisturizing the skin or providing the skin with medical properties by adhering the material to the face.
[EXAMPLES]
[0145] Hereafter, the invention will be further described in detail with reference to the following examples, but the invention is not limited to the examples. In addition, unless it otherwise specified, "part" and "%" refer to "part by mass" and "% by mass", respectively.
[0146] [Example 1]
The following components were stirred upon heating at 50°C for one hour to obtain a sol-state solution 1.
• Acid processed gelatin (derived from pig skin origin) 3.0g
• 1,3-butanediol 5.0g . PLURONIC F- 127
(PEO-PPO-PEO block polymer: manufactured by BASF A.G.) 0.5g
• Pure water 41.5g
[0147] The sol solution 1 was subjected to a casting to form a thickness of lmm in a case
made from polystyrene with a size of 65mm x 95mm, and cooled at 40C for 16 hours to obtain a hydrogel for Example 1. The hydrogel was referred to as the gel sheet of Example 1. The transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 85%. [0148] [Example 2]
A hydrogel of Example 2 was obtained by a method similar to the manufacturing process of the hydrogel of Example 1 except that PLURONIC F- 127 was replaced with polymethyl vinylether, and the hydrogel of Example 2 was referred to as the gel sheet of Example 2. The transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 72%. [0149] [Example 3]
A hydrogel of Example 3 was obtained by a method similar to the manufacturing process of the hydrogel of Example 1 except that PLURONIC F- 127 was replaced with methylcellulose, and the hydrogel of Example 3 was referred to as the gel sheet of Example 3. The transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 84%. [0150] [Example 4]
< Preparation of Carotenoid-Containing Emulsion >
The following components were dissolved upon heating at 7O0C for one hour, and a water-phase composition was obtained.
• Sucrose oleate 13g
• Monooleic acid decaglyceryl 25g
• Glycerin 50Og
• Pure water 322g
[0151] The following components were dissolved upon heating at 70°C for one hour and an oil-phase composition was obtained.
• Haematococcus Pluvialis extract (astaxanthins content 20 % by mass) 4Og
• Mix Tocopherol 1Og
• Lecithin (derived from soybean) 9Og [0152] The above oil-phase composition was added to the water-phase composition with stirring by means of a homogenizer (10,000rpm), while maintaining at 70°C, and a carotenoid-containing emulsion was obtained. The resultant carotenoid-containing emulsion was subjected to a high-pressure emulsification at a pressure of 200MPa using ULTIMIZER HJP-25005 (manufactured by Sugino Machine Limited). The volume average particle diameter of the obtained emulsion was measured by a thickened system particle size analyzer FPAR-1000 (Otsuka Electronics Co., Ltd.) at 25°C and the volume average particle diameter of 90nm was obtained.
[0153] < Preparation of Hydrogel >
The following components were heated and kneaded at 80°C, and a sol-state product 2 was obtained.
• K-carragheenan 0.2g
• Gulcomannan (derived from elephant root) 0.2g
• Acid processed gelatin (derived from pig skin) 0.5g
• PLURONIC F- 127 -
(PEO-PPO-PEO block polymer: manufactured by BASF A.G.) 0.5g
• 1,3-butanediol 5.Og
• Pure water 43.1g [0154] After the sol-state product 2 was cooled to 60°C, 0.5g of the
carotenoid-containing emulsion was added thereto, and the mixture was uniformly stirred to obtain a solution. The solution was subjected to a casting to form a thickness of lmm in a case made from polystyrene with a size of 65mm x 95mm, and cooled at 4°C for 16 hours to obtain a hydrogel for Example 4. The hydrogel was referred to as the gel sheet of Example 4. The transmittance of the gel sheet at the wavelength of 600nm by use of a spectrophotometer was 80%. [0155] [Comparative Example 1]
The following components was stirred upon heating at 50°C for one hour, and a sol-state solution 3 was obtained.
• Acid processed gelatin (derived from pig skin) 3.0g
• 1,3-butanediol 5.0g
• Pure water 42.Og [0156] The sol-state solution 3 was subjected to a casting to form a thickness of lmm in a case made from polystyrene with a size of 65mm x 95mm, and cooled at 4°C for 16 hours to obtain a hydrogel. The hydrogel was referred to as the gel sheet of Comparative Example 1.
[0157] [Comparative Example 2]
The following components were heated and kneaded at 80°C, and a sol-state product 4 was obtained.
• K-carragheenan 0.2g
• Gulcomannan (derived from elephant root) 0.2g
• PLURONIC F- 127
(PEO-PPO-PEO block polymer: manufactured by BASF A.G.) 0.5g
• 1,3-butanediol 5.Og
• Pure water 44.1g
[0158] The sol-state solution 4 was subjected to a casting to form a thickness of lmm in a case made from polystyrene with a size of 65mm x 95mm, and cooled at 40C for 16 hours to obtain a hydrogel. The hydrogel was referred to as the gel sheet of Comparative Example 2. [0159] [Comparative Example 3]
Polyethyleneglycol-copolybutylene naphthalate was dissolved in THF so as to become a concentration of 10% by mass. The solution was subjected to a casting on a tray made of TEFLON (registered trademark) with a size of 5 cm x 5 cm, and died at ordinary temperature and pressure to form a film. The film was immersed into 100ml of pure water, and a hydrogel was obtained. The hydrogel was referred to as the gel sheet of Comparative Example 3. [0160] [Comparative Example 4]
A hydrogel was obtained by a method similar to the manufacturing process of the hydrogel of Example 1 except that PLURONIC F- 127 was replaced with poly (N-isopropylacrylamide). The hydrogel was referred to as the gel sheet of Comparative Example 4.
[0161] - Evaluation of Gel Sheet -
The gel sheets of Examples 1 to 4 and Comparative Example 1 to 4 were actually used by graders such that the gel sheet was adhered onto the face for each grader (gel sheet was adhered onto eye area of each grader for fifteen minutes after face wash), evaluations were conducted in accordance with the following methods and criteria, and the evaluation results are shown in Table 1 below. The evaluation results are shown as the mean values of the evaluation results by five graders.
[0162] (l) Operability
Evaluations were conducted in such a manner that in the case that when the gel sheet was adhered onto the face, the gel sheet was easily adhered without being stuck on the graders' fingers, the gel sheet was rated at A; in the case that it took a time for adhering due to sticking of the sheet on the graders' fingers, the gel sheet was rated at B; and in the case that when the gel sheet was easily broken and adhering was difficult, the gel sheet was rated at C. [0163] (2) Sense of Adhesion
In the operations of the above "(1) operability", the sense of adhesion was evaluated in such a manner that, in the case that when the gel sheet adhered onto the face came into close contact with the face along the surface thereof, the gel sheet was rated at A; when the gel sheet came off in part; the gel sheet was rated at B; and when the gel sheet got wrinkles, and a number of portions of the gel sheet were exfoliated, the gel sheet was rated at C. [0164] (3) Moisture-Retaining Property
The gel sheet was stuck for 15 minutes, and after the gel sheet was exfoliated, the amount of the water content in the keratin layer after a lapse of 30 minutes was measured with a keratin layer aquameter (manufactured by Asahibiomed). The moisture-retaining property was evaluated in such as manner that in the case that when an increase in the water content was 10% or more at the mean value of the evaluated values by the five graders, the gel sheet was rated at A; in the case that when an increase in the water content was from 2 % to 10%, the gel sheet was rated at B; and in the case that when an increase in the water content was less than 2 %, the gel sheet was rated at C. [0165] (4) Skin Barrier Property
In order to evaluate an improvement function of rough dry skin, the transepidermal water loss (TEWL) was measured by the following methods.
That is, a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the transepidermal water loss (TEWL) immediately after exfoliation of the gel sheet on the third day was measured by a transepidermal water loss meter (manufactured by Asahibiomed). The skin barrier property was evaluated in such a manner that in the case that when the TEWL value dropped to 5% or more as compared with the value before the test, the gel sheet was rated at A; in the case that when the drop was from 1 to 4%, the gel sheet was rated at B; and in the case that when the TEWL value was not changed, the gel sheet was rated at C.
[0166] Table 1
[0167] As shown in Table 1, it is clear that all the gel sheets in Examples 1 - 4 are excellent in the operability, tight fit feeling, moisture-retaining property and skin barrier
property. Accordingly, it is clear that the gel sheets having such as excellent effects are also excellent as sheet-like cosmetic materials. [0168] Example 5
< Preparation of O/W Type Emulsion >
The following components were dissolved upon heating at 7O0C for one hour, and a water-phase composition was obtained.
• Sucrose oleate 15g
• Monooleic acid decaglyceryl 23g
• Glycerin 500g
• Pure water 322g
Further, the following components were dissolved upon heating at 70°C for one hour and an oil-phase composition was obtained.
• Haematococcus Pluvialis extract (astaxanthins content 20 % by mass) 4Og
• Mix Tocopherol 1Og
• Lecithin (derived from soybean) 9Og [0169] The above water-phase composition was added to the oil-phase composition with stirring by means of a homogenizer (10,000rpm), while maintaining at 70°C, and an emulsion was obtained. The resultant emulsion was subjected to a high-pressure emulsification at a pressure of 200MPa using ULTIMIZER HJP-25005 (manufactured by Sugino Machine Limited). The volume average particle diameter of the obtained emulsion was measured by a thickened system particle size analyzer FPAR-1000 (Otsuka Electronics Co., Ltd.) at 250C and the volume average particle diameter of 90nm was obtained.
[0170] < Preparation of Hydrogel >
The components except for the emulsion among the components described in Table 2 were successively added to water, and heated and kneaded at 80°C, to obtain a sol-state product.
After cooling this sol product to 600C, the above O/W type emulsion was added to the sol product, and stirred uniformly. After extending the resultant hydrogel using a doctor blade so as to form a thickness of 0.8mm, the hydrogel was covered with a mesh nylon fabric with a basis weight of 20g/m2 and allowed to stand at 25 °C for 30 minutes so that the gel sheet of Example 5 having the nylon mesh sheet as the sheet-like substrate with hydrogel layers on both surfaces of the substrate was obtained. The total thickness of the hydrogel layers was 0.8mm.
In addition, the numerical values showing amounts of components in Table 2 are expressed in terms of parts by mass. [0171] [Example 6 - 8 and Comparative Examples 5 - 8]
As shown in Table 2, each component was used in a manner similar to Example 5, adhesive gel sheets for living bodies according to Examples 5 - 8, and Comparative Examples 5 - 8 were obtained. [0172] (Evaluation of Adhesive Gel Sheet for Living Body)
Using the adhesive gel sheet for living bodies of Examples 5 - 8, and Comparative Examples 5 - 8, the following evaluations were performed and the evaluation results are shown in Table 2 below. In addition, each functional evaluation of the adhesiveness, moisture-retaining property, skin barrier property, and effect for making the skin beautiful was made by ten graders (adhered onto the face) using the gel sheets of Examples 5 - 8, and Comparative Examples 5 - 8, and the mean values of the evaluation results are shown in Table 2.
[0173] (1) Syneresis Rate
The adhesive gel sheets for living bodies of Examples 5 - 8, and Comparative Examples 5 - 8 were cut into a size of 3cm x 3cm to form sample gel sheets, and these sample gel sheets were interposed between No.2 filter paper manufactured by Advantec MSF. Inc., so as to be two sheets of the filter paper for each of the upper and lower sides of the sample gel sheets, and the change of the mass of the filter paper was measured when allowing to stand under the circumstances of 25°C and the relative humidity of 55% for 10 minutes. The syneresis rate was calculated by the formula shown below using the obtained measured values. The test was reiterated five times and the mean values thereof are shown in Table 2.
Syneresis rate (% by mass) -
(mass of absorbed liquid by filter paper/initial mass of gel) x 100
Here, the "initial mass of gel" was obtained by subtracting the mass of the nylon mesh as the sheet substrate from the mass of the sample gel sheet test piece. [0174] (2) Coloration of Syneresis Liquid
The coloration degree of the liquid-absorbed filter paper was estimated in the evaluation of the syneresis rate.
When coloration originated from carotenoids was clearly observed, the sample was rated at A, when slight coloration was observed, the sample was rated at B, and when coloration was not visually distinctive, the sample was rated at C. [0175] (3) Content Ratio of Emulsion in Syneresis Liquid
Astaxanthin contained in the filter paper was extracted in such a manner that 5 parts by mass of water and 4 parts of acetone were added to one part of absorbed liquid in the liquid absorbed filter paper in the evaluations of the syneresis rate. For comparison, 5
parts by mass of water and 4 parts of acetone were added to one part of the blended liquid for forming hydrogel, and the absorbance at 473nm of the resultant extraction liquid was measured by a spectrophotometer (V-630: manufactured by JASCO Corporation), and the content ratio of emulsion in the syneresis liquid was calculated according to the following formula:
Content ratio of emulsion in syneresis liquid =
Absorbance at 473nm of syneresis liquid extraction liquid/
Absorbance at 473nm of blended liquid for forming hydrogel [0176] (4) Water Content
One gram of each hydrogel layer taken out from the gel sheets in Examples 5 - 8 and Comparative Examples 5 - 8 was dried at 250C under reduced pressure. The drying was continued until the mass change of the sample was not observed, and the water content was calculated according to the following formula:
Water content (%) =
[(initial mass - mass after drying) / initial mass] x 100
The above measuring test was reiterated five times and the mean values thereof were rated at the water content. [0177] (5) Sense of Adhesion
The sense of adhesion was evaluated in such a manner that when the gel sheet adhered onto the face came into close contact with the face along the surface thereof, the gel sheet was rated at A; when the gel sheet came off in part; the gel sheet was rated at B; and when the gel sheet got wrinkles, and a number of portions of the gel sheet were exfoliated, the gel sheet was rated at C. [0178] (6) Moisture-Retaining Property
Before the gel sheet was adhered, the water content of the keratin layer at the eye area in the face for ten graders was measured with a keratin layer aquameter (manufactured by Asahibiomed), and evaluated in terms of conductance value. Thereafter, the gel sheet was stuck for 15 minutes, and after the gel sheet was peeled off, the amount of the water content in the keratin layer after a lapse of 30 minutes was measured with a keratin layer aquameter (manufactured by Asahibiomed) as the value of the conductance. Comparison between the values before adhering and after adhering was made for ten graders, and when an increase in the mean value of conductance was 10% or more, the gel sheet was rated at AA, when an increase from 2% to 10% was observed, the gel sheet was rated at B, and when an increase was less than 2%, the gel sheet was rated at C. [0179] (7) Skin Barrier Property
In order to evaluate an improvement function of rough dry skin, the transepidermal water loss (TEWL) was measured by the following methods.
That is, a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the transepidermal water loss (TEWL) immediately after exfoliation of the gel sheet on the third day was measured by a transepidermal water loss meter (manufactured by Asahibiomed). The skin barrier property was evaluated in such a manner that when the TEWL value dropped to 5% or more as compared with the value before the test, the gel sheet was rated at A; when the drop was from 1 to 4%, the gel sheet was In order to evaluate an improvement function of rough dry skin, the transepidermal water loss (TEWL) was measured by the following methods. [0180] That is, a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the transepidermal water loss (TEWL) immediately after peeling off the gel sheet on the third day was measured by a transepidermal water loss meter
(manufactured by Asahibiomed). The skin barrier property was evaluated in such a manner that in the case that when the TEWL value dropped to 5% or more as compared with the value before the test, the gel sheet was rated at A; when the drop was from 1 to 4%, the gel sheet was rated at B; and when the change of the TEWL value was not observed, the gel sheet was rated at C. [0181] (8) Functional Evaluation
When a gel sheet was adhered periodically for 15 minutes a day for three consecutive days, and the impression of the appearance of the skin immediately after peeling off the adhesive gel sheet for living bodies on the third day was evaluated. When a clear feeling of improvement of the skin texture was obtained, the gel sheet was rated at A; when subtle feeling of improvement of the skin texture was obtained, the gel sheet was rated at B, and when improvement of the skin texture was not felt, the gel sheet was rated at C.
[0182]
Table 2
n.d. : Not detected
[0183] From the results of Table 2, it is clear that the syneresis rate of the adhesive gel sheets for living bodies in Examples 5 - 8 is high, and the O/W type emulsion particles are contained in the syneresis liquid. Moreover, it becomes clear that the improvement effect of the moisture-retaining property, skin barrier property and skin texture are excellent.
On the other hand, with the adhesive gel sheets for living bodies in the Comparative Examples 5 - 8, the quantities of the syneresis liquid are small, and the emulsion is not contained in the syneresis liquid, actual feelings of improvements particularly in the functional evaluations cannot obtained, and moisturizing effect is also insufficient.
[0184] The disclosure of Japanese Patent Applications No. 2007-244489 is incorporated by reference herein.
All publications, patent applications, and technical standards mentioned in this specification are herein incorporated by reference to the same extent as if such individual publication, patent application, or technical standard was specifically and individually indicated to be incorporated by reference. It will be obvious to those having skill in the art that many changes may be made in the above-described details of the preferred embodiments of the present invention. The scope of the invention, therefore, should be determined by the following claims.
Claims
1. A gel sheet comprising a hydrogel which comprises an ether-based temperature-sensitive polymer, and at least one of collagen or decomposition products of collagen.
2. The gel sheet according to claim 1, wherein the ether-based temperature-sensitive polymer is at least one selected from the group consisting of polyethers, polyvinyl ethers, and alkylated polysaccharide derivatives.
3. The gel sheet according to claim 2, wherein the one of the polyethers, polyvinyl ethers, and alkylated polysaccharide derivatives has at least one functional group selected from the group consisting of an oxyethylene group, an oxypropylene group, a methoxy group, and an ethoxy group.
4. The gel sheet according to any of claims 1-3, wherein the ether-based polymer is a block polymer containing polyethylene oxide and polypropylene oxide.
5. The gel sheet according to any of claims 1-4, wherein the gel sheet further comprises an O/W type emulsion.
6. The gel sheet according to claim 5, wherein the O/W type emulsion comprises a carotenoid.
7. The gel sheet according to claim 5 or claim 6, wherein the average particle diameter of the emulsified particles of the O/W type emulsion is l-150nm.
8. The gel sheet according to any of claims 5-7, wherein the emulsified particles of the OAV type emulsion are included in a syneresis liquid of the gel sheet.
9. The gel sheet according to any of claims 1-8, wherein the gel sheet comprises a hydrogel formed by using an anionic polymer compound and water-soluble divalent metal salt.
10. The gel sheet according to any of claims 1-9, wherein the gel sheet further comprises a polysaccharide.
11. The gel sheet according to any of claims 1-10, wherein the gel sheet further comprises a polyhydric alcohol compound.
12. The gel sheet according to any of claims 1-11, wherein the water content of the gel sheet is from 70% by mass to 95% by mass.
13. The gel sheet according to any of claims 1-12, wherein the gel sheet comprises a hydrogel layer containing the hydrogel and a sheet-like substrate provided in the hydrogel layer or adjacent to the hydrogel gel layer.
14. The gel sheet according to any of claims 1-13, wherein the thickness of the gel sheet is from 0.4mm to 2mm.
15. A sheet-like cosmetic material using any one of the gel sheets according to claims 1-14.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007244489 | 2007-09-20 | ||
JP2007-244489 | 2007-09-20 | ||
JP2007-284508 | 2007-10-31 | ||
JP2007284508A JP5653573B2 (en) | 2007-09-20 | 2007-10-31 | Gel sheet and sheet cosmetic using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009038030A1 true WO2009038030A1 (en) | 2009-03-26 |
Family
ID=40001389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/066614 WO2009038030A1 (en) | 2007-09-20 | 2008-09-09 | Gel sheet and sheet-like cosmetic material using the same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009038030A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10406079B2 (en) | 2015-11-30 | 2019-09-10 | Kimberly-Clark Worldwide, Inc. | Structures containing thermo-sensitive gels |
US10433700B2 (en) | 2013-11-27 | 2019-10-08 | Kimberly-Clark Worldwide, Inc. | Multi-purpose tough stain removal articles |
WO2020036526A1 (en) * | 2018-08-13 | 2020-02-20 | Gelexcell Competence Ab | A biphasic hydrogel formulation and methods of production and use thereof |
US10849834B2 (en) | 2014-02-17 | 2020-12-01 | Cosmed Pharmaceutical Co., Ltd. | Cosmetic gel sheet and manufacturing method thereof |
US11382843B2 (en) | 2016-04-28 | 2022-07-12 | Cosmed Pharmaceutical Co., Ltd. | Alcogel sheet for cosmetic use, and method for producing same |
CN114886844A (en) * | 2022-05-31 | 2022-08-12 | 安徽工程大学 | Enzymatic reaction regulation-based chitosan/gamma-polyglutamic acid/tannic acid hydrogel and preparation method and application thereof |
WO2024178530A1 (en) * | 2023-02-27 | 2024-09-06 | L'oreal | Composition for caring for keratin materials in the form of hydrogel |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0381213A (en) * | 1989-08-24 | 1991-04-05 | Kobayashi Kose Co Ltd | Pack |
JPH05184657A (en) * | 1992-01-09 | 1993-07-27 | Terumo Corp | Adhesive composite for skin and adhesive sheet for medical use |
JPH1192554A (en) * | 1997-09-18 | 1999-04-06 | Teijin Ltd | Polyether ester type temperature-responsive hydrogel |
JP2003212760A (en) * | 2002-01-17 | 2003-07-30 | Lion Corp | Gel composition and gel sheet |
US20050037079A1 (en) * | 2003-08-14 | 2005-02-17 | Taewon Son | Temperature sensitive state-changing hydrogel composition and method for preparation |
EP1543828A1 (en) * | 2003-12-19 | 2005-06-22 | Shin-Etsu Chemical Co., Ltd. | Gel sheet and preparation method thereof |
-
2008
- 2008-09-09 WO PCT/JP2008/066614 patent/WO2009038030A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0381213A (en) * | 1989-08-24 | 1991-04-05 | Kobayashi Kose Co Ltd | Pack |
JPH05184657A (en) * | 1992-01-09 | 1993-07-27 | Terumo Corp | Adhesive composite for skin and adhesive sheet for medical use |
JPH1192554A (en) * | 1997-09-18 | 1999-04-06 | Teijin Ltd | Polyether ester type temperature-responsive hydrogel |
JP2003212760A (en) * | 2002-01-17 | 2003-07-30 | Lion Corp | Gel composition and gel sheet |
US20050037079A1 (en) * | 2003-08-14 | 2005-02-17 | Taewon Son | Temperature sensitive state-changing hydrogel composition and method for preparation |
EP1543828A1 (en) * | 2003-12-19 | 2005-06-22 | Shin-Etsu Chemical Co., Ltd. | Gel sheet and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
DATABASE WPI Week 199120, Derwent World Patents Index; AN 1991-144795, XP002508241 * |
DATABASE WPI Week 199334, Derwent World Patents Index; AN 1993-269080, XP002508239 * |
DATABASE WPI Week 199924, Derwent World Patents Index; AN 1999-283612, XP002508240 * |
DATABASE WPI Week 200382, Derwent World Patents Index; AN 2003-883024, XP002508242 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10433700B2 (en) | 2013-11-27 | 2019-10-08 | Kimberly-Clark Worldwide, Inc. | Multi-purpose tough stain removal articles |
US10849834B2 (en) | 2014-02-17 | 2020-12-01 | Cosmed Pharmaceutical Co., Ltd. | Cosmetic gel sheet and manufacturing method thereof |
US11701309B2 (en) | 2014-02-17 | 2023-07-18 | Cosmed Pharmaceutical Co., Ltd. | Cosmetic gel sheet and manufacturing method thereof |
US10406079B2 (en) | 2015-11-30 | 2019-09-10 | Kimberly-Clark Worldwide, Inc. | Structures containing thermo-sensitive gels |
US11382843B2 (en) | 2016-04-28 | 2022-07-12 | Cosmed Pharmaceutical Co., Ltd. | Alcogel sheet for cosmetic use, and method for producing same |
WO2020036526A1 (en) * | 2018-08-13 | 2020-02-20 | Gelexcell Competence Ab | A biphasic hydrogel formulation and methods of production and use thereof |
EP3836977A4 (en) * | 2018-08-13 | 2022-05-04 | Gelexcell Competence AB | TWO-PHASE HYDROGEL FORMULATION AND PROCESS FOR THEIR PREPARATION AND USE |
CN114886844A (en) * | 2022-05-31 | 2022-08-12 | 安徽工程大学 | Enzymatic reaction regulation-based chitosan/gamma-polyglutamic acid/tannic acid hydrogel and preparation method and application thereof |
CN114886844B (en) * | 2022-05-31 | 2023-05-23 | 安徽工程大学 | A chitosan/γ-polyglutamic acid/tannic acid hydrogel based on enzymatic reaction regulation and its preparation method and application |
WO2024178530A1 (en) * | 2023-02-27 | 2024-09-06 | L'oreal | Composition for caring for keratin materials in the form of hydrogel |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100239621A1 (en) | Gel sheet and cosmetic preparation in sheet form using the same | |
CN101801332B (en) | Adhesive gel sheet for living body and sheet cosmetic containing same | |
WO2009038030A1 (en) | Gel sheet and sheet-like cosmetic material using the same | |
JP5653573B2 (en) | Gel sheet and sheet cosmetic using the same | |
WO2009106338A2 (en) | Cosmetic of dermopharmaceutical composition of mixed micelles | |
JP7588890B2 (en) | Foaming skin care product | |
BRPI0709228A2 (en) | cosmetic use of whey protein micelles | |
JP2008137970A (en) | Pressure-sensitive adhesive gel sheet for living body and sheet-like cosmetic using the same | |
JP2009513709A (en) | Cosmetic skin care application using mineral-derived tubules for controlled release | |
KR102099269B1 (en) | Two-part skin care formulations | |
JP4230221B2 (en) | Manufacturing method of biomedical adhesive gel sheet | |
JP2008285461A (en) | Self-adhesive gel sheet for living organism and sheet-like cosmetic comprising the same | |
JP3524501B2 (en) | Cosmetics | |
WO2021020560A1 (en) | Pigment including cellulose | |
ITMI20080636A1 (en) | PATCH FOR DERMAL USE | |
KR20190122641A (en) | Skin application method of cellulose membrane, cosmetic for application | |
JP2009108008A (en) | Gel sheet and sheet-like cosmetic using the same | |
JP2009108006A (en) | Method for producing gel sheet, gel sheet and sheet-like cosmetic | |
JP2008255066A (en) | New cosmetic composition for pack | |
JP7656352B2 (en) | Foaming skin care product | |
JP2009108005A (en) | Gel sheet and sheet-like cosmetic | |
JP2010150173A (en) | Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation | |
JP3910346B2 (en) | Sheet cosmetic | |
WO2019190531A1 (en) | Rapidly dissolving collagen-based cosmetic films and methods thereof | |
JP6648230B2 (en) | Skin preparation kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08832141 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08832141 Country of ref document: EP Kind code of ref document: A1 |